Search ADRC


  1. Aarsland D, Bronnick K, Williams-Gray C, Weintraub D, Marder K, Kulisevsky J, et al. Mild cognitive impairment in Parkinson disease: a multicenter pooled analysis. Neurology. 2010;75(12):1062-9. doi: 10.1212/WNL.0b013e3181f39d0e. PubMed PMID: 20855849; PubMed Central PMCID: PMC2942065.
  2. Alcalay RN, Caccappolo E, Mejia-Santana H, Tang M, Rosado L, Orbe Reilly M, et al. Cognitive performance of GBA mutation carriers with early-onset PD: the CORE-PD study. Neurology. 2012;78(18):1434-40. doi: 10.1212/WNL.0b013e318253d54b. PubMed PMID: 22442429; PubMed Central PMCID: PMC3345785.
  3. Alcalay RN, Caccappolo E, Mejia-Santana H, Tang MX, Rosado L, Orbe Reilly M, et al. Cognitive and motor function in long-duration PARKIN-associated Parkinson disease. JAMA neurology. 2014;71(1):62-7. doi: 10.1001/jamaneurol.2013.4498.
  4. Alcalay RN, Caccappolo E, Mejia-Santana H, Tang MX, Rosado L, Orbe Reilly M, et al. Cognitive performance of GBA mutation carriers with early-onset PD: The CORE-PD study. Neurology. 2012. Epub 2012/03/24. doi: 10.1212/WNL.0b013e318253d54b. PubMed PMID: 22442429; PubMed Central PMCID: PMC3345785.
  5. Alcalay RN, Caccappolo E, Mejia-Santana H, Tang MX, Rosado L, Ross BM, et al. Frequency of known mutations in early-onset Parkinson disease: implication for genetic counseling: the consortium on risk for early onset Parkinson disease study. Archives of neurology. 2010;67(9):1116-22. Epub 2010/09/15. doi: 67/9/1116 [pii] 10.1001/archneurol.2010.194. PubMed PMID: 20837857; PubMed Central PMCID: PMC3329730.
  6. Alcalay RN, Mejia-Santana H, Tang MX, Rakitin B, Rosado L, Ross B, et al. Self-report of cognitive impairment and mini-mental state examination performance in PRKN, LRRK2, and GBA carriers with early onset Parkinson's disease. J Clin Exp Neuropsychol. 2010;32(7):775-9. Epub 2010/02/26. doi: 919484122 [pii] 10.1080/13803390903521018. PubMed PMID: 20182943; PubMed Central PMCID: PMC2911493.
  7. Alcalay RN, Mirelman A, Saunders-Pullman R, Tang MX, Mejia Santana H, Raymond D, et al. Parkinson disease phenotype in Ashkenazi Jews with and without LRRK2 G2019S mutations. Movement disorders : official journal of the Movement Disorder Society. 2013;28(14):1966-71. doi: 10.1002/mds.25647. PubMed PMID: 24243757; PubMed Central PMCID: PMC3859844.
  8. Alcalay RN, Siderowf A, Ottman R, Caccappolo E, Mejia-Santana H, Tang MX, et al. Olfaction in Parkin heterozygotes and compound heterozygotes: the CORE-PD study. Neurology. 2011;76(4):319-26. Epub 2011/01/06. doi: WNL.0b013e31820882aa [pii] 10.1212/WNL.0b013e31820882aa. PubMed PMID: 21205674; PubMed Central PMCID: PMC3034420.
  9. Ali WH, Chen Q, Delgiorno KE, Su W, Hall JC, Hongu T, et al. Deficiencies of the lipid-signaling enzymes phospholipase d1 and d2 alter cytoskeletal organization, macrophage phagocytosis, and cytokine-stimulated neutrophil recruitment. PloS one. 2013;8(1):e55325. doi: 10.1371/journal.pone.0055325. PubMed PMID: 23383154; PubMed Central PMCID: PMC3557251.
  10. Allen M, Zou F, Chai HS, Younkin CS, Crook J, Pankratz VS, et al. Novel late-onset Alzheimer disease loci variants associate with brain gene expression. Neurology. 2012;79(3):221-8. doi: 10.1212/WNL.0b013e3182605801. PubMed PMID: 22722634; PubMed Central PMCID: PMC3398432.
  11. Armstrong N, Schupf N, Grafman J, Huey ED. Caregiver burden in frontotemporal degeneration and corticobasal syndrome. Dement Geriatr Cogn Disord. 2013;36(5-6):310-8. doi: 10.1159/000351670. PubMed PMID: 24022248; PubMed Central PMCID: PMC Journal - In Process.
  12. Armstrong RA, Ellis W, Hamilton RL, Mackenzie IR, Hedreen J, Gearing M, et al. Neuropathological heterogeneity in frontotemporal lobar degeneration with TDP-43 proteinopathy: a quantitative study of 94 cases using principal components analysis. J Neural Transm. 2010;117(2):227-39. Epub 2009/12/17. doi: 10.1007/s00702-009-0350-6. PubMed PMID: 20012109; PubMed Central PMCID: PMC2830004.
  13. Babij R, Lee M, Cortes E, Vonsattel JP, Faust PL, Louis ED. Purkinje cell axonal anatomy: quantifying morphometric changes in essential tremor versus control brains. Brain : a journal of neurology. 2013;136(Pt 10):3051-61. doi: 10.1093/brain/awt238. PubMed PMID: 24030953; PubMed Central PMCID: PMC3784286.
  14. Bakken TE, Roddey JC, Djurovic S, Akshoomoff N, Amaral DG, Bloss CS, et al. Association of common genetic variants in GPCPD1 with scaling of visual cortical surface area in humans. Proc Natl Acad Sci U S A. 2012;109(10):3985-90. doi: 10.1073/pnas.1105829109. PubMed PMID: 22343285; PubMed Central PMCID: PMC3309762.
  15. Barral S, Bird T, Goate A, Farlow MR, Diaz-Arrastia R, Bennett DA, et al. Genotype patterns at PICALM, CR1, BIN1, CLU, and APOE genes are associated with episodic memory. Neurology. 2012;78(19):1464-71. doi: 10.1212/WNL.0b013e3182553c48. PubMed PMID: 22539578; PubMed Central PMCID: PMC3345618.
  16. Barral S, Cosentino S, Costa R, Andersen SL, Christensen K, Eckfeldt JH, et al. Exceptional memory performance in the Long Life Family Study. Neurobiology of aging. 2013;34(11):2445-8. doi: 10.1016/j.neurobiolaging.2013.05.002. PubMed PMID: 23759147; PubMed Central PMCID: PMC Journal - In Process.
  17. Barral S, Cosentino S, Costa R, Matteini A, Christensen K, Andersen SL, et al. Cognitive function in families with exceptional survival. Neurobiology of aging. 2012;33(3):619 e1-7. doi: 10.1016/j.neurobiolaging.2011.02.004. PubMed PMID: 21439683; PubMed Central PMCID: PMC3126873.
  18. Barral S, Fernandez-Cadenas I, Bis JC, Montaner J, Ikram AM, Launer LJ, et al. No association of ALOX5AP polymorphisms with risk of MRI-defined brain infarcts. Neurobiology of aging. 2012;33(3):629 e1-3. doi: 10.1016/j.neurobiolaging.2011.10.010. PubMed PMID: 22074807; PubMed Central PMCID: PMC3259245.
  19. Bartres-Faz D, Arenaza-Urquijo EM. Structural and functional imaging correlates of cognitive and brain reserve hypotheses in healthy and pathological aging. Brain topography. 2011;24(3-4):340-57. doi: 10.1007/s10548-011-0195-9. PubMed PMID: 21853422.
  20. Barulli D, Stern Y. Efficiency, capacity, compensation, maintenance, plasticity: emerging concepts in cognitive reserve. Trends Cogn Sci. 2013;17(10):502-9. doi: 10.1016/j.tics.2013.08.012. PubMed PMID: 24018144; PubMed Central PMCID: PMC3840716.
  21. Barulli DJ, Rakitin BC, Lemaire P, Stern Y. The influence of cognitive reserve on strategy selection in normal aging. J Int Neuropsychol Soc. 2013;19(7):841-4. doi: 10.1017/S1355617713000593. PubMed PMID: 23714237; PubMed Central PMCID: PMC3755348.
  22. Bateman RJ, Xiong C, Benzinger TL, Fagan AM, Goate A, Fox NC, et al. Clinical and biomarker changes in dominantly inherited Alzheimer's disease. N Engl J Med. 2012;367(9):795-804. doi: 10.1056/NEJMoa1202753. PubMed PMID: 22784036; PubMed Central PMCID: PMC3474597.
  23. Beck ES, Gasque G, Imlach WL, Jiao W, Jiwon Choi B, Wu PS, et al. Regulation of Fasciclin II and synaptic terminal development by the splicing factor beag. J Neurosci. 2012;32(20):7058-73. doi: 10.1523/JNEUROSCI.3717-11.2012. PubMed PMID: 22593074; PubMed Central PMCID: PMC3375121.
  24. Bell KL. Memory Loss and Dementia: Mild Cognitive Impairment. In: Brust J, editor. Current Diagnosis and Treatment in Neurology. 2nd ed. New York, NY: McGraw Hill-Medical; 2011. p. 85.
  25. Bell KL, Williamson JL, Janicki SC. Memory Loss and Dementia: Alzheimer Disease. In: Brust J, editor. Current Diagnosis and Treatment in Neurology. 2nd ed. New York, NY: McGraw Hill-Medical; 2011. p. 78-84.
  26. Benitez BA, Jin SC, Guerreiro R, Graham R, Lord J, Harold D, et al. Missense variant in TREML2 protects against Alzheimer's disease. Neurobiology of aging. 2013. doi: 10.1016/j.neurobiolaging.2013.12.010. PubMed PMID: 24439484; PubMed Central PMCID: PMC3961557.
  27. Benzinger TL, Blazey T, Jack CR, Jr., Koeppe RA, Su Y, Xiong C, et al. Regional variability of imaging biomarkers in autosomal dominant Alzheimer's disease. Proc Natl Acad Sci U S A. 2013;110(47):E4502-9. doi: 10.1073/pnas.1317918110. PubMed PMID: 24194552; PubMed Central PMCID: PMC3839740.
  28. Bettens K, Brouwers N, Engelborghs S, Lambert JC, Rogaeva E, Vandenberghe R, et al. Both common variations and rare non-synonymous substitutions and small insertion/deletions in CLU are associated with increased Alzheimer risk. Mol Neurodegener. 2012;7:3. doi: 10.1186/1750-1326-7-3. PubMed PMID: 22248099; PubMed Central PMCID: PMC3296573.
  29. Bhalla A, Vetanovetz CP, Morel E, Chamoun Z, Di Paolo G, Small SA. The location and trafficking routes of the neuronal retromer and its role in amyloid precursor protein transport. Neurobiology of disease. 2012;47(1):126-34. doi: 10.1016/j.nbd.2012.03.030. PubMed PMID: 22516235; PubMed Central PMCID: PMC3589992.
  30. Blum S, Luchsinger JA, Manly JJ, Schupf N, Stern Y, Brown TR, et al. Memory after silent stroke: hippocampus and infarcts both matter. Neurology. 2012;78(1):38-46. doi: 10.1212/WNL.0b013e31823ed0cc. PubMed PMID: 22201111; PubMed Central PMCID: PMC3466498.
  31. Blumen HM, Gopher D, Steinerman JR, Stern Y. Training cognitive control in older adults with the space fortress game: the role of training instructions and basic motor ability. Front Aging Neurosci. 2010;2:145. Epub 2010/12/02. doi: 10.3389/fnagi.2010.00145. PubMed PMID: 21120135; PubMed Central PMCID: PMC2991174.
  32. Blumen HM, Stern Y. Short-term and long-term collaboration benefits on individual recall in younger and older adults. Mem Cognit. 2011;39(1):147-54. Epub 2011/01/26. doi: 10.3758/s13421-010-0023-6. PubMed PMID: 21264617; PubMed Central PMCID: PMC3071579.
  33. Borogovac A, Habeck C, Small SA, Asllani I. Mapping brain function using a 30-day interval between baseline and activation: a novel arterial spin labeling fMRI approach. Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism. 2010;30(10):1721-33. Epub 2010/07/22. doi: jcbfm201089 [pii] 10.1038/jcbfm.2010.89. PubMed PMID: 20648039; PubMed Central PMCID: PMC3023398.
  34. Boxer AL, Gold M, Huey E, Hu WT, Rosen H, Kramer J, et al. The advantages of frontotemporal degeneration drug development (part 2 of frontotemporal degeneration: the next therapeutic frontier). Alzheimers Dement. 2013;9(2):189-98. doi: 10.1016/j.jalz.2012.03.003. PubMed PMID: 23062850; PubMed Central PMCID: PMC3562382.
  35. Brickman AM. Contemplating Alzheimer's disease and the contribution of white matter hyperintensities. Current neurology and neuroscience reports. 2013;13(12):415. doi: 10.1007/s11910-013-0415-7. PubMed PMID: 24190781; PubMed Central PMCID: PMC3874404.
  36. Brickman AM, Provenzano FA, Muraskin J, Manly JJ, Blum S, Apa Z, et al. Regional white matter hyperintensity volume, not hippocampal atrophy, predicts incident Alzheimer disease in the community. Archives of neurology. 2012;69(12):1621-7. doi: 10.1001/archneurol.2012.1527. PubMed PMID: 22945686; PubMed Central PMCID: PMC3597387.
  37. Brickman AM, Reitz C, Luchsinger JA, Manly JJ, Schupf N, Muraskin J, et al. Long-term blood pressure fluctuation and cerebrovascular disease in an elderly cohort. Archives of neurology. 2010;67(5):564-9. Epub 2010/05/12. doi: 67/5/564 [pii] 10.1001/archneurol.2010.70. PubMed PMID: 20457955; PubMed Central PMCID: PMC2917204.
  38. Brickman AM, Siedlecki KL, Muraskin J, Manly JJ, Luchsinger JA, Yeung LK, et al. White matter hyperintensities and cognition: testing the reserve hypothesis. Neurobiology of aging. 2011;32(9):1588-98. Epub 2009/11/21. doi: 10.1016/j.neurobiolaging.2009.10.013. PubMed PMID: 19926168; PubMed Central PMCID: PMC2891625.
  39. Brickman AM, Stern Y, Small SA. Hippocampal subregions differentially associate with standardized memory tests. Hippocampus. 2010. Epub 2010/09/09. doi: 10.1002/hipo.20840. PubMed PMID: 20824727; PubMed Central PMCID: PMC3008756.
  40. Brown PJ, Liu X, Sneed JR, Pimontel MA, Devanand DP, Roose SP. Speed of processing and depression affect function in older adults with mild cognitive impairment. Am J Geriatr Psychiatry. 2013;21(7):675-84. doi: 10.1016/j.jagp.2013.01.005. PubMed PMID: 23567401; PubMed Central PMCID: PMC3410965.
  41. Brown PJ, Roose SP, Fieo R, Liu X, Rantanen T, Sneed JR, et al. Frailty and Depression in Older Adults: A High-Risk Clinical Population. Am J Geriatr Psychiatry. 2013. doi: 10.1016/j.jagp.2013.04.010. PubMed PMID: 23973252; PubMed Central PMCID: PMC3930630.
  42. Brown PJ, Sneed JR, Rutherford BR, Devanand DP, Roose SP. The nuances of cognition and depression in older adults: the need for a comprehensive assessment. Int J Geriatr Psychiatry. 2013. doi: 10.1002/gps.4033. PubMed PMID: 24123357; PubMed Central PMCID: PMC3975802.
  43. Caccappolo E, Alcalay RN, Mejia-Santana H, Tang MX, Rakitin B, Rosado L, et al. Neuropsychological profile of Parkin mutation carriers with and without Parkinson disease: The CORE-PD study. J Int Neuropsychol Soc. 2011;17(1):91-100. Epub 2010/11/26. doi: S1355617710001190 [pii] 10.1017/S1355617710001190. PubMed PMID: 21092386; PubMed Central PMCID: PMC3366462.
  44. Chan RB, Di Paolo G. Knockout punch: cardiolipin oxidation in trauma. Nature neuroscience. 2012;15(10):1325-7. doi: 10.1038/nn.3222. PubMed PMID: 23007184; PubMed Central PMCID: PMC Journal - In Process.
  45. Chan RB, Oliveira TG, Cortes EP, Honig LS, Duff KE, Small SA, et al. Comparative lipidomic analysis of mouse and human brain with Alzheimer disease. The Journal of biological chemistry. 2012;287(4):2678-88. doi: 10.1074/jbc.M111.274142. PubMed PMID: 22134919; PubMed Central PMCID: PMC3268426.
  46. Chang-Ileto B, Frere SG, Di Paolo G. Acute manipulation of phosphoinositide levels in cells. Methods Cell Biol. 2012;108:187-207. doi: 10.1016/B978-0-12-386487-1.00010-9. PubMed PMID: 22325604; PubMed Central PMCID: PMC3543678.
  47. Chen Q, Hongu T, Sato T, Zhang Y, Ali W, Cavallo JA, et al. Key roles for the lipid signaling enzyme phospholipase d1 in the tumor microenvironment during tumor angiogenesis and metastasis. Sci Signal. 2012;5(249):ra79. doi: 10.1126/scisignal.2003257. PubMed PMID: 23131846; PubMed Central PMCID: PMC3721670.
  48. Cheng D, Noble J, Tang MX, Schupf N, Mayeux R, Luchsinger JA. Type 2 diabetes and late-onset Alzheimer's disease. Dement Geriatr Cogn Disord. 2011;31(6):424-30. Epub 2011/07/16. doi: 10.1159/000324134. PubMed PMID: 21757907; PubMed Central PMCID: PMC3142096.
  49. Chhatwal JP, Schultz AP, Johnson K, Benzinger TL, Jack C, Jr., Ances BM, et al. Impaired default network functional connectivity in autosomal dominant Alzheimer disease. Neurology. 2013;81(8):736-44. doi: 10.1212/WNL.0b013e3182a1aafe. PubMed PMID: 23884042; PubMed Central PMCID: PMC3776464.
  50. Cho SJ, Scarmeas N, Jang TW, Marder K, Tang MX, Honig LS. Importance of symptomatic cerebral infarcts on cognitive performance in patients with Alzheimer's disease. J Korean Med Sci. 2011;26(3):412-6. Epub 2011/03/12. doi: 10.3346/jkms.2011.26.3.412. PubMed PMID: 21394311; PubMed Central PMCID: PMC3051090.
  51. Chouraki V, De Bruijn RF, Chapuis J, Bis JC, Reitz C, Schraen S, et al. A genome-wide association meta-analysis of plasma Abeta peptides concentrations in the elderly. Molecular psychiatry. 2014. doi: 10.1038/mp.2013.185. PubMed PMID: 24535457; PubMed Central PMCID: PMC Journal - In Process.
  52. Chun YS, Shin S, Kim Y, Cho H, Park MK, Kim TW, et al. Cholesterol modulates ion channels via down-regulation of phosphatidylinositol 4,5-bisphosphate. J Neurochem. 2010;112(5):1286-94. Epub 2009/12/18. doi: JNC6545 [pii] 10.1111/j.1471-4159.2009.06545.x [doi]. PubMed PMID: 20015154; PubMed Central PMCID: PMC2891522.
  53. Clark LN, Kisselev S, Park N, Ross B, Verbitsky M, Rios E, et al. Mutations in the Parkinson's disease genes, Leucine Rich Repeat Kinase 2 (LRRK2) and Glucocerebrosidase (GBA), are not associated with essential tremor. Parkinsonism & related disorders. 2010;16(2):132-5. Epub 2009/06/17. doi: S1353-8020(09)00134-5 [pii] 10.1016/j.parkreldis.2009.05.008. PubMed PMID: 19527940; PubMed Central PMCID: PMC2822079.
  54. Clark LN, Liu X, Parmalee NL, Hernandez N, Louis ED. The microtubule associated protein tau H1 haplotype and risk of essential tremor. Eur J Neurol. 2013. doi: 10.1111/ene.12335. PubMed PMID: 24372973; PubMed Central PMCID: PMC Journal - In Process.
  55. Clark LN, Park N, Kisselev S, Rios E, Lee JH, Louis ED. Replication of the LINGO1 gene association with essential tremor in a North American population. Eur J Hum Genet. 2010;18(7):838-43. Epub 2010/04/08. doi: ejhg201027 [pii] 10.1038/ejhg.2010.27. PubMed PMID: 20372186; PubMed Central PMCID: PMC2987362.
  56. 56. Clelland CL, Clelland JD. MicroRNAs in neurodegenerative disorders. Genomics, Proteomics, and the Nervous System. New York: Springer; 2010. p. 445-54.
  57. Coppola G, Chinnathambi S, Lee JJ, Dombroski BA, Baker MC, Soto-Ortolaza AI, et al. Evidence for a role of the rare p.A152T variant in MAPT in increasing the risk for FTD-spectrum and Alzheimer's diseases. Hum Mol Genet. 2012;21(15):3500-12. doi: 10.1093/hmg/dds161. PubMed PMID: 22556362; PubMed Central PMCID: PMC3392107.
  58. Cosentino S, Metcalfe J, Holmes B, Steffener J, Stern Y. Finding the self in metacognitive evaluations: metamemory and agency in nondemented elders. Neuropsychology. 2011;25(5):602-12. Epub 2011/07/07. doi: 10.1037/a0023972. PubMed PMID: 21728426; PubMed Central PMCID: PMC3160506.
  59. Cosentino S, Schupf N, Christensen K, Andersen SL, Newman A, Mayeux R. Reduced prevalence of cognitive impairment in families with exceptional longevity. JAMA neurology. 2013;70(7):867-74. doi: 10.1001/jamaneurol.2013.1959. PubMed PMID: 23649824; PubMed Central PMCID: PMC Journal - In Process.
  60. Cosentino SA, Stern Y, Sokolov E, Scarmeas N, Manly JJ, Tang MX, et al. Plasma B-amyloid and cognitive decline. Archives of neurology. 2010;67(12):1485-90. Epub 2010/08/11. doi: archneurol.2010.189 [pii] 10.1001/archneurol.2010.189. PubMed PMID: 20697031; PubMed Central PMCID: PMC3006003.
  61. Cossec JC, Lavaur J, Berman DE, Rivals I, Hoischen A, Stora S, et al. Trisomy for synaptojanin1 in Down syndrome is functionally linked to the enlargement of early endosomes. Hum Mol Genet. 2012;21(14):3156-72. doi: 10.1093/hmg/dds142. PubMed PMID: 22511594; PubMed Central PMCID: PMC3384382.
  62. Cruchaga C, Haller G, Chakraverty S, Mayo K, Vallania FL, Mitra RD, et al. Rare variants in APP, PSEN1 and PSEN2 increase risk for AD in late-onset Alzheimer's disease families. PloS one. 2012;7(2):e31039. doi: 10.1371/journal.pone.0031039. PubMed PMID: 22312439; PubMed Central PMCID: PMC3270040.
  63. Cruchaga C, Kauwe JS, Harari O, Jin SC, Cai Y, Karch CM, et al. GWAS of cerebrospinal fluid tau levels identifies risk variants for Alzheimer's disease. Neuron. 2013;78(2):256-68. doi: 10.1016/j.neuron.2013.02.026. PubMed PMID: 23562540; PubMed Central PMCID: PMC3664945.
  64. Dall'Armi C, Devereaux KA, Di Paolo G. The role of lipids in the control of autophagy. Curr Biol. 2013;23(1):R33-45. doi: 10.1016/j.cub.2012.10.041. PubMed PMID: 23305670; PubMed Central PMCID: PMC3587843.
  65. Dall'armi C, Hurtado-Lorenzo A, Tian H, Morel E, Nezu A, Chan RB, et al. The phospholipase D1 pathway modulates macroautophagy. Nature communications. 2010;1(9):142. Epub 2011/01/27. doi: 10.1038/ncomms1144 ncomms1144 [pii]. PubMed PMID: 21266992; PubMed Central PMCID: PMC3328354.
  66. Devanand D, Lee J, Luchsinger J, Manly J, Marder K, Mayeux R, et al. Lessons from epidemiologic research about risk factors, modifiers, and progression of late onset Alzheimer's Disease in New York City at Columbia University Medical Center. Journal of Alzheimer's disease : JAD. 2013;33 Suppl 1:S447-55. doi: 10.3233/JAD-2012-129041. PubMed PMID: 22836187; PubMed Central PMCID: PMC Journal - In Process.
  67. Devanand DP. Psychosis, agitation, and antipsychotic treatment in dementia. Am J Psychiatry. 2013;170(9):957-60. doi: 10.1176/appi.ajp.2013.13060767. PubMed PMID: 24030608; PubMed Central PMCID: PMC Journal - In Process.
  68. Devanand DP. Dysthymic disorder in the elderly population. Int Psychogeriatr. 2014;26(1):39-48. doi: 10.1017/S104161021300166X. PubMed PMID: 24152873; PubMed Central PMCID: PMC Journal - In Process.
  69. Devanand DP, Bansal R, Liu J, Hao X, Pradhaban G, Peterson BS. MRI hippocampal and entorhinal cortex mapping in predicting conversion to Alzheimer's disease. Neuroimage. 2012;60(3):1622-9. doi: 10.1016/j.neuroimage.2012.01.075. PubMed PMID: 22289801; PubMed Central PMCID: PMC3320768.
  70. Devanand DP, Liu X, Brown PJ, Huey ED, Stern Y, Pelton GH. A two-study comparison of clinical and MRI markers of transition from mild cognitive impairment to Alzheimer's disease. Int J Alzheimers Dis. 2012;2012:483469. doi: 10.1155/2012/483469. PubMed PMID: 22482070; PubMed Central PMCID: PMC3296186.
  71. Devanand DP, Mintzer J, Schultz S, Sultzer D, de la Pena D, Gupta S, et al. The antipsychotic discontinuation in Alzheimer disease trial: clinical rationale and study design. Am J Geriatr Psychiatry. 2012;20(4):362-73. doi: 10.1097/JGP.0b013e3182110563. PubMed PMID: 21407047; PubMed Central PMCID: PMC3146556.
  72. Devanand DP, Mintzer J, Schultz SK, Andrews HF, Sultzer DL, de la Pena D, et al. Relapse risk after discontinuation of risperidone in Alzheimer's disease. N Engl J Med. 2012;367(16):1497-507. doi: 10.1056/NEJMoa1114058. PubMed PMID: 23075176; PubMed Central PMCID: PMC3490406.
  73. Devanand DP, Pelton GH, Cunqueiro K, Sackeim HA, Marder K. A 6-month, randomized, double-blind, placebo-controlled pilot discontinuation trial following response to haloperidol treatment of psychosis and agitation in Alzheimer's disease. Int J Geriatr Psychiatry. 2011;26(9):937-43. Epub 2011/08/17. doi: 10.1002/gps.2630. PubMed PMID: 21845596; PubMed Central PMCID: PMC3685500.
  74. Devanand DP, Roose SP. Antidepressants in older adults: complexities, confounds and clinical effects. Am J Geriatr Psychiatry. 2014;22(1):1-3. doi: 10.1016/j.jagp.2013.09.008. PubMed PMID: 24314886; PubMed Central PMCID: PMC Journal - In Process.
  75. Devanand DP, Schultz SK, Sultzer DL. Discontinuation of risperidone in Alzheimer's disease. N Engl J Med. 2013;368(2):187-8. doi: 10.1056/NEJMc1214030. PubMed PMID: 23301737; PubMed Central PMCID: PMC Journal - In Process.
  76. Devanand DP, Schupf N, Stern Y, Parsey R, Pelton GH, Mehta P, et al. Plasma Abeta and PET PiB binding are inversely related in mild cognitive impairment. Neurology. 2011;77(2):125-31. Epub 2011/07/01. doi: 10.1212/WNL.0b013e318224afb7. PubMed PMID: 21715709; PubMed Central PMCID: PMC3140071.
  77. Devanand DP, Tabert MH, Cuasay K, Manly JJ, Schupf N, Brickman AM, et al. Olfactory identification deficits and MCI in a multi-ethnic elderly community sample. Neurobiology of aging. 2010;31(9):1593-600. Epub 2008/10/31. doi: S0197-4580(08)00331-X [pii] 10.1016/j.neurobiolaging.2008.09.008. PubMed PMID: 18963256; PubMed Central PMCID: PMC2947189.
  78. Devanand DP, Van Heertum RL, Kegeles LS, Liu X, Jin ZH, Pradhaban G, et al. (99m)Tc hexamethyl-propylene-aminoxime single-photon emission computed tomography prediction of conversion from mild cognitive impairment to Alzheimer disease. Am J Geriatr Psychiatry. 2010;18(11):959-72. Epub 2010/09/03. doi: 10.1097/JGP.0b013e3181ec8696. PubMed PMID: 20808143; PubMed Central PMCID: PMC3103107.
  79. Devereaux K, Dall'Armi C, Alcazar-Roman A, Ogasawara Y, Zhou X, Wang F, et al. Regulation of mammalian autophagy by class II and III PI 3-kinases through PI3P synthesis. PloS one. 2013;8(10):e76405. doi: 10.1371/journal.pone.0076405. PubMed PMID: 24098492; PubMed Central PMCID: PMC3789715.
  80. Devereaux K, Di Paolo G. PI5P migrates out of the PIP shadow. EMBO Rep. 2013;14(3):214-5. doi: 10.1038/embor.2013.2. PubMed PMID: 23392221; PubMed Central PMCID: PMC3589091.
  81. Devier DJ, Villemarette-Pittman N, Brown P, Pelton G, Stern Y, Sano M, et al. Predictive utility of type and duration of symptoms at initial presentation in patients with mild cognitive impairment. Dement Geriatr Cogn Disord. 2010;30(3):238-44. Epub 2010/09/18. doi: 000320137 [pii] 10.1159/000320137. PubMed PMID: 20847554; PubMed Central PMCID: PMC2948660.
  82. Di Paolo G, Kim TW. Linking lipids to Alzheimer's disease: cholesterol and beyond. Nature reviews Neuroscience. 2011;12(5):284-96. Epub 2011/03/31. doi: 10.1038/nrn3012. PubMed PMID: 21448224; PubMed Central PMCID: PMC3321383.
  83. Di Paolo G, Przedborski S. When Schwann cells conspire with mitochondria, neighboring axons are under attack by glia-derived neurotoxic lipids. Neuron. 2013;77(5):801-3. doi: 10.1016/j.neuron.2013.02.016. PubMed PMID: 23473310; PubMed Central PMCID: PMC Journal - In Process.
  84. Di Pardo A, Alberti S, Maglione V, Amico E, Cortes EP, Elifani F, et al. Changes of peripheral TGF-beta1 depend on monocytes-derived macrophages in Huntington disease. Mol Brain. 2013;6:55. doi: 10.1186/1756-6606-6-55. PubMed PMID: 24330808; PubMed Central PMCID: PMC Journal - In Process.
  85. Drye LT, Ismail Z, Porsteinsson AP, Rosenberg PB, Weintraub D, Marano C, et al. Citalopram for agitation in Alzheimer's disease: design and methods. Alzheimers Dement. 2012;8(2):121-30. doi: 10.1016/j.jalz.2011.01.007. PubMed PMID: 22301195; PubMed Central PMCID: PMC3333484.
  86. Dubois B, Feldman HH, Jacova C, Cummings JL, Dekosky ST, Barberger-Gateau P, et al. Revising the definition of Alzheimer's disease: a new lexicon. Lancet neurology. 2010;9(11):1118-27. Epub 2010/10/12. doi: S1474-4422(10)70223-4 [pii] 10.1016/S1474-4422(10)70223-4. PubMed PMID: 20934914; PubMed Central PMCID: PMC Journal – In Process.
  87. Dumont M, Stack C, Elipenahli C, Jainuddin S, Gerges M, Starkova N, et al. Bezafibrate administration improves behavioral deficits and tau pathology in P301S mice. Hum Mol Genet. 2012;21(23):5091-105. doi: 10.1093/hmg/dds355. PubMed PMID: 22922230; PubMed Central PMCID: PMC3490516.
  88. Eich TS, Stern Y, Metcalfe J. The hypercorrection effect in younger and older adults. Neuropsychol Dev Cogn B Aging Neuropsychol Cogn. 2013;20(5):511-21. doi: 10.1080/13825585.2012.754399. PubMed PMID: 23241028; PubMed Central PMCID: PMC3604148.
  89. Elvers M, Grenegard M, Khoshjabinzadeh H, Munzer P, Borst O, Tian H, et al. A novel role for phospholipase D as an endogenous negative regulator of platelet sensitivity. Cell Signal. 2012;24(9):1743-52. doi: 10.1016/j.cellsig.2012.04.018. PubMed PMID: 22579635; PubMed Central PMCID: PMC Journal - In Process.
  90. Erickson-Davis CR, Faust PL, Vonsattel JP, Gupta S, Honig LS, Louis ED. "Hairy baskets" associated with degenerative Purkinje cell changes in essential tremor. Journal of neuropathology and experimental neurology. 2010;69(3):262-71. Epub 2010/02/10. doi: 10.1097/NEN.0b013e3181d1ad04. PubMed PMID: 20142764; PubMed Central PMCID: PMC2865233.
  91. Ewers M, Insel PS, Stern Y, Weiner MW, Alzheimer's Disease Neuroimaging I. Cognitive reserve associated with FDG-PET in preclinical Alzheimer disease. Neurology. 2013;80(13):1194-201. doi: 10.1212/WNL.0b013e31828970c2. PubMed PMID: 23486873; PubMed Central PMCID: PMC3691784.
  92. Fagan AM, Xiong C, Jasielec MS, Bateman RJ, Goate AM, Benzinger TL, et al. Longitudinal Change in CSF Biomarkers in Autosomal-Dominant Alzheimer's Disease. Science translational medicine. 2014;6(226):226ra30. doi: 10.1126/scitranslmed.3007901. PubMed PMID: 24598588; PubMed Central PMCID: PMC Journal - In Process.
  93. Ferrari R, Kapogiannis D, Huey ED, Momeni P. FTD and ALS: a tale of two diseases. Current Alzheimer research. 2011;8(3):273-94. Epub 2011/01/13. PubMed PMID: 21222600; PubMed Central PMCID: PMC3801195.
  94. Ferrari R, Mok K, Moreno JH, Cosentino S, Goldman J, Pietrini P, et al. Screening for C9ORF72 repeat expansion in FTLD. Neurobiology of aging. 2012;33(8):1850 e1-11. doi: 10.1016/j.neurobiolaging.2012.02.017. PubMed PMID: 22459598; PubMed Central PMCID: PMC3743244.
  95. Fieo R, Manly JJ, Schupf N, Stern Y. Functional Status in the Young-Old: Establishing a Working Prototype of an Extended-Instrumental Activities of Daily Living Scale. J Gerontol A Biol Sci Med Sci. 2013. doi: 10.1093/gerona/glt167. PubMed PMID: 24149431; PubMed Central PMCID: PMC Journal - In Process.
  96. Finan GM, Okada H, Kim TW. BACE1 retrograde trafficking is uniquely regulated by the cytoplasmic domain of sortilin. The Journal of biological chemistry. 2010. Epub 2011/01/20. doi: M110.170217 [pii] 10.1074/jbc.M110.170217 [doi]. PubMed PMID: 21245145; PubMed Central PMCID: PMC3069461.
  97. Frere SG, Chang-Ileto B, Di Paolo G. Role of phosphoinositides at the neuronal synapse. Subcell Biochem. 2012;59:131-75. doi: 10.1007/978-94-007-3015-1_5. PubMed PMID: 22374090; PubMed Central PMCID: PMC3543677.
  98. Friedman D, Honig LS, Scarmeas N. Seizures and epilepsy in Alzheimer's disease. CNS Neurosci Ther. 2012;18(4):285-94. doi: 10.1111/j.1755-5949.2011.00251.x. PubMed PMID: 22070283; PubMed Central PMCID: PMC3630499.
  99. Gazes Y, Rakitin BC, Steffener J, Habeck C, Butterfield B, Ghez C, et al. Performance degradation and altered cerebral activation during dual performance: evidence for a bottom-up attentional system. Behavioural brain research. 2010;210(2):229-39. Epub 2010/03/02. doi: S0166-4328(10)00149-X [pii] 10.1016/j.bbr.2010.02.036. PubMed PMID: 20188768; PubMed Central PMCID: PMC3531229.
  100. Gazzaley A, Small SA. Alzheimer's disease. Network. 2011;22(1-4):173-85. Epub 2011/12/14. doi: 10.3109/0954898X.2011.638696. PubMed PMID: 22149678; PubMed Central PMCID: PMC Journal - In Process.
  101. Geerlings MI, Brickman AM, Schupf N, Devanand DP, Luchsinger JA, Mayeux R, et al. Depressive symptoms, antidepressant use, and brain volumes on MRI in a population-based cohort of old persons without dementia. Journal of Alzheimer's disease : JAD. 2012;30(1):75-82. doi: 10.3233/JAD-2012-112009. PubMed PMID: 22377782; PubMed Central PMCID: PMC3348270.
  102. Gerhard T, Huybrechts K, Olfson M, Schneeweiss S, Bobo WV, Doraiswamy PM, et al. Comparative mortality risks of antipsychotic medications in community-dwelling older adults. Br J Psychiatry. 2013. doi: 10.1192/bjp.bp.112.122499. PubMed PMID: 23929443; PubMed Central PMCID: PMC Journal - In Process.
  103. Ghani M, Pinto D, Lee JH, Grinberg Y, Sato C, Moreno D, et al. Genome-wide survey of large rare copy number variants in Alzheimer's disease among Caribbean hispanics. G3 (Bethesda). 2012;2(1):71-8. doi: 10.1534/g3.111.000869. PubMed PMID: 22384383; PubMed Central PMCID: PMC3276183.
  104. Ghani M, Sato C, Lee JH, Reitz C, Moreno D, Mayeux R, et al. Evidence of recessive Alzheimer disease loci in a Caribbean Hispanic data set: genome-wide survey of runs of homozygosity. JAMA neurology. 2013;70(10):1261-7. doi: 10.1001/jamaneurol.2013.3545. PubMed PMID: 23978990; PubMed Central PMCID: PMC Journal - In Process.
  105. Glymour MM, Kosheleva A, Wadley VG, Weiss C, Manly JJ. Geographic distribution of dementia mortality: elevated mortality rates for black and white americans by place of birth. Alzheimer disease and associated disorders. 2011;25(3):196-202. Epub 2011/02/08. doi: 10.1097/WAD.0b013e31820905e7. PubMed PMID: 21297428; PubMed Central PMCID: PMC3383774.
  106. Goldman JS, Hahn SE, Catania JW, LaRusse-Eckert S, Butson MB, Rumbaugh M, et al. Genetic counseling and testing for Alzheimer disease: joint practice guidelines of the American College of Medical Genetics and the National Society of Genetic Counselors. Genetics in medicine : official journal of the American College of Medical Genetics. 2011;13(6):597-605. Epub 2011/05/18. doi: 10.1097/GIM.0b013e31821d69b8. PubMed PMID: 21577118; PubMed Central PMCID: PMC3326653.
  107. Goldman JS, Rademakers R, Huey ED, Boxer AL, Mayeux R, Miller BL, et al. An algorithm for genetic testing of frontotemporal lobar degeneration. Neurology. 2011;76(5):475-83. Epub 2011/02/02. doi: 10.1212/WNL.0b013e31820a0d13. PubMed PMID: 21282594; PubMed Central PMCID: PMC3034412.
  108. Gordon LT, Soldan A, Thomas AK, Stern Y. Effect of repetition lag on priming of unfamiliar visual objects in young and older adults. Psychology and aging. 2013;28(1):219-31. doi: 10.1037/a0030929. PubMed PMID: 23276220; PubMed Central PMCID: PMC3769096.
  109. Gordon PH, Goetz RR, Rabkin JG, Dalton K, McElhiney M, Hays AP, et al. A prospective cohort study of neuropsychological test performance in ALS. Amyotroph Lateral Scler. 2010;11(3):312-20. Epub 2010/03/17. doi: 10.3109/17482961003622585. PubMed PMID: 20225929; PubMed Central PMCID: PMC Journal – In Process.
  110. Gu Y, Luchsinger JA, Stern Y, Scarmeas N. Mediterranean diet, inflammatory and metabolic biomarkers, and risk of Alzheimer's disease. Journal of Alzheimer's disease : JAD. 2010;22(2):483-92. Epub 2010/09/18. doi: T51410J2707749R6 [pii] 10.3233/JAD-2010-100897. PubMed PMID: 20847399; PubMed Central PMCID: PMC3022949.
  111. Gu Y, Nieves JW, Luchsinger JA, Scarmeas N. Dietary inflammation factor rating system and risk of Alzheimer disease in elders. Alzheimer disease and associated disorders. 2011;25(2):149-54. doi: 10.1097/WAD.0b013e3181ff3c6a. PubMed PMID: 21606905; PubMed Central PMCID: PMC3101483.
  112. Gu Y, Nieves JW, Stern Y, Luchsinger JA, Scarmeas N. Food combination and Alzheimer disease risk: a protective diet. Archives of neurology. 2010;67(6):699-706. Epub 2010/04/14. doi: 2010.84 [pii] 10.1001/archneurol.2010.84. PubMed PMID: 20385883; PubMed Central PMCID: PMC3029147.
  113. Gu Y, Scarmeas N. Dietary patterns in Alzheimer's disease and cognitive aging. Current Alzheimer research. 2011;8(5):510-9. PubMed PMID: 21605048; PubMed Central PMCID: PMC3283139.
  114. Gu Y, Scarmeas N, Cosentino S, Brandt J, Albert M, Blacker D, et al. Change in Body Mass Index Before and After Alzheimer's Disease Onset. Current Alzheimer research. 2013. PubMed PMID: 24251397; PubMed Central PMCID: PMC Journal - In Process.
  115. Gu Y, Scarmeas N, Short EE, Luchsinger JA, Decarli C, Stern Y, et al. Alcohol intake and brain structure in a multiethnic elderly cohort. Clinical nutrition. 2013. doi: 10.1016/j.clnu.2013.08.004. PubMed PMID: 24011900; PubMed Central PMCID: PMC Journal - In Process.
  116. Gutierrez J, Rosoklija G, Murray J, Chon C, Elkind MS, Goldman J, et al. A quantitative perspective to the study of brain arterial remodeling of donors with and without HIV in the Brain Arterial Remodeling Study (BARS). Front Physiol. 2014;5:56. doi: 10.3389/fphys.2014.00056. PubMed PMID: 24600402; PubMed Central PMCID: PMC3928551.
  117. Habeck C, Stern Y. Multivariate data analysis for neuroimaging data: overview and application to Alzheimer's disease. Cell Biochem Biophys. 2010;58(2):53-67. Epub 2010/07/27. doi: 10.1007/s12013-010-9093-0. PubMed PMID: 20658269; PubMed Central PMCID: PMC3001346.
  118. Hadzi TC, Hendricks AE, Latourelle JC, Lunetta KL, Cupples LA, Gillis T, et al. Assessment of cortical and striatal involvement in 523 Huntington disease brains. Neurology. 2012;79(16):1708-15. doi: 10.1212/WNL.0b013e31826e9a5d. PubMed PMID: 23035064; PubMed Central PMCID: PMC3468776.
  119. Harms M, Benitez BA, Cairns N, Cooper B, Cooper P, Mayo K, et al. C9orf72 hexanucleotide repeat expansions in clinical Alzheimer disease. JAMA neurology. 2013;70(6):736-41. doi: 10.1001/2013.jamaneurol.537. PubMed PMID: 23588422; PubMed Central PMCID: PMC3681841.
  120. Hernandez AI, Oxberry WC, Crary JF, Mirra SS, Sacktor TC. Cellular and subcellular localization of PKMzeta. Philosophical transactions of the Royal Society of London Series B, Biological sciences. 2014;369(1633):20130140. doi: 10.1098/rstb.2013.0140. PubMed PMID: 24298142; PubMed Central PMCID: PMC3843872.
  121. Heyer EJ, Mergeche JL, Stern Y, Malone HR, Bruce SS, Ward JT, et al. Apolipoprotein E-epsilon4 polymorphism and cognitive dysfunction after carotid endarterectomy. J Clin Neurosci. 2014;21(2):236-40. doi: 10.1016/j.jocn.2013.04.009. PubMed PMID: 24139138; PubMed Central PMCID: PMC3947092.
  122. Hobart J, Cano S, Posner H, Selnes O, Stern Y, Thomas R, et al. Putting the Alzheimer's cognitive test to the test II: Rasch Measurement Theory. Alzheimers Dement. 2013;9(1 Suppl):S10-20. doi: 10.1016/j.jalz.2012.08.006. PubMed PMID: 23253779; PubMed Central PMCID: PMC Journal - In Process.
  123. Hobart J, Cano S, Posner H, Selnes O, Stern Y, Thomas R, et al. Putting the Alzheimer's cognitive test to the test I: traditional psychometric methods. Alzheimers Dement. 2013;9(1 Suppl):S4-9. doi: 10.1016/j.jalz.2012.08.005. PubMed PMID: 23253777; PubMed Central PMCID: PMC Journal - In Process.
  124. Hollingworth P, Sweet R, Sims R, Harold D, Russo G, Abraham R, et al. Genome-wide association study of Alzheimer's disease with psychotic symptoms. Molecular psychiatry. 2012;17(12):1316-27. doi: 10.1038/mp.2011.125. PubMed PMID: 22005930; PubMed Central PMCID: PMC3272435.
  125. Holton P, Ryten M, Nalls M, Trabzuni D, Weale ME, Hernandez D, et al. Initial assessment of the pathogenic mechanisms of the recently identified Alzheimer risk Loci. Ann Hum Genet. 2013;77(2):85-105. doi: 10.1111/ahg.12000. PubMed PMID: 23360175; PubMed Central PMCID: PMC3578142.
  126. Honig LS. Normal Pressure Hydrocephalus (NPH). In: Rowland LP, Pedley TA, editors. Merritt’s Neurology. 12 ed. Philadelphia: Wolters Kluwer LWW; 2010 p. 356-7.
  127. Honig LS. Dementia – General Considerations. In: Rowland LP, Pedley TA, editors. Merritt’s Neurology. 12 ed. Philadelphia: Wolters Kluwer LWW; 2010 p. 710-2.
  128. Honig LS. Normal Pressure Hydrocephalus. In: Brust J, editor. Current Diagnosis and Treatment in Neurology. 2nd ed. New York, NY: McGraw Hill-Medical; 2011. p. 96-8.
  129. Honig LS. Prion Diseases. In: Brust J, editor. Current Diagnosis and Treatment in Neurology. 2nd ed. New York, NY: McGraw Hill-Medical; 2011. p. 475-8.
  130. Honig LS. Vascular Dementia. In: Brust J, editor. Current Diagnosis and Treatment in Neurology. 2nd ed. New York, NY: McGraw Hill-Medical; 2011. p. 85-7.
  131. Honig LS. Translational research in neurology: dementia. Archives of neurology. 2012;69(8):969-77. doi: 10.1001/archneurol.2011.2883. PubMed PMID: 22473767; PubMed Central PMCID: PMC3644591.
  132. Honig LS, Boyd CD. Treatment of Alzheimer's Disease: Current Management and Experimental Therapeutics. Curr Transl Geriatr Exp Gerontol Rep. 2013;2(3):174-81. doi: 10.1007/s13670-013-0056-3. PubMed PMID: 24093080; PubMed Central PMCID: PMC3786221.
  133. Honig LS, Kang MS, Schupf N, Lee JH, Mayeux R. Association of shorter leukocyte telomere repeat length with dementia and mortality. Archives of neurology. 2012;69(10):1332-9. doi: 10.1001/archneurol.2012.1541. PubMed PMID: 22825311; PubMed Central PMCID: PMC3622729.
  134. Huey ED, Ferrari R, Moreno JH, Jensen C, Morris CM, Potocnik F, et al. FUS and TDP43 genetic variability in FTD and CBS. Neurobiology of aging. 2012;33(5):1016 e9-17. doi: 10.1016/j.neurobiolaging.2011.08.004. PubMed PMID: 21943958; PubMed Central PMCID: PMC Journal - In Process.
  135. Huey ED, Manly JJ, Tang MX, Schupf N, Brickman AM, Manoochehri M, et al. Course and etiology of dysexecutive MCI in a community sample. Alzheimers Dement. 2013. doi: 10.1016/j.jalz.2012.10.014. PubMed PMID: 23452959; PubMed Central PMCID: PMC3933297.
  136. Huey ED, Nagy PL, Rodriguez-Murillo L, Manoochehri M, Goldman J, Lieberman J, et al. C9ORF72 repeat expansions not detected in a group of patients with schizophrenia. Neurobiology of aging. 2013;34(4):1309 e9-10. doi: 10.1016/j.neurobiolaging.2012.08.011. PubMed PMID: 23036583; PubMed Central PMCID: PMC3584690.
  137. Imlach WL, Beck ES, Choi BJ, Lotti F, Pellizzoni L, McCabe BD. SMN is required for sensory-motor circuit function in Drosophila. Cell. 2012;151(2):427-39. doi: 10.1016/j.cell.2012.09.011. PubMed PMID: 23063130; PubMed Central PMCID: PMC3475188.
  138. Janicki SC. Dementia and Memory Loss: Progressive supranuclear palsy, and corticobasal ganglionic degeneration. . In: Brust J, editor. Current Diagnosis and Treatment in Neurology. 2nd ed. New York, NY: McGraw Hill-Medical; 2011. p. 90-2.
  139. Janicki SC, Cosentino S, Louis ED. The cognitive side of essential tremor: what are the therapeutic implications? Ther Adv Neurol Disord. 2013;6(6):353-68. doi: 10.1177/1756285613489591. PubMed PMID: 24228071; PubMed Central PMCID: PMC3825113.
  140. Janicki SC, Park N, Cheng R, Lee JH, Schupf N, Clark LN. Estrogen Receptor beta Variants Modify Risk for Alzheimer's Disease in a Multiethnic Female Cohort. Journal of Alzheimer's disease : JAD. 2014;40(1):83-93. doi: 10.3233/JAD-130551. PubMed PMID: 24326520; PubMed Central PMCID: PMC Journal - In Process.
  141. Janicki SC, Park N, Cheng R, Schupf N, Clark LN, Lee JH. Aromatase variants modify risk for Alzheimer's disease in a multiethnic female cohort. Dement Geriatr Cogn Disord. 2013;35(5-6):340-6. doi: 10.1159/000343074. PubMed PMID: 23635391; PubMed Central PMCID: PMC Journal - In Process.
  142. Jones RN, Manly J, Glymour MM, Rentz DM, Jefferson AL, Stern Y. Conceptual and measurement challenges in research on cognitive reserve. J Int Neuropsychol Soc. 2011:1-9. Epub 2011/03/18. doi: S1355617710001748 [pii] 10.1017/S1355617710001748. PubMed PMID: 21411036; PubMed Central PMCID: PMC3289742.
  143. Jun G, Naj AC, Beecham GW, Wang LS, Buros J, Gallins PJ, et al. Meta-analysis confirms CR1, CLU, and PICALM as alzheimer disease risk loci and reveals interactions with APOE genotypes. Archives of neurology. 2010;67(12):1473-84. Epub 2010/08/11. doi: archneurol.2010.201 [pii] 10.1001/archneurol.2010.201. PubMed PMID: 20697030; PubMed Central PMCID: PMC3048805.
  144. Jun G, Vardarajan BN, Buros J, Yu CE, Hawk MV, Dombroski BA, et al. Comprehensive search for Alzheimer disease susceptibility loci in the APOE region. Archives of neurology. 2012;69(10):1270-9. doi: 10.1001/archneurol.2012.2052. PubMed PMID: 22869155; PubMed Central PMCID: PMC3579659.
  145. Kang MS, Baek SH, Chun YS, Moore AZ, Landman N, Berman D, et al. Modulation of lipid kinase PI4KIIalpha activity and lipid raft association of presenilin 1 underlies gamma-secretase inhibition by ginsenoside (20S)-Rg3. The Journal of biological chemistry. 2013;288(29):20868-82. doi: 10.1074/jbc.M112.445734. PubMed PMID: 23723072; PubMed Central PMCID: PMC3774358.
  146. Khachaturian ZS, Petersen RC, Snyder PJ, Khachaturian AS, Aisen P, de Leon M, et al. Developing a global strategy to prevent Alzheimer's disease: Leon Thal Symposium 2010. Alzheimers Dement. 2011;7(2):127-32. Epub 2011/03/19. doi: 10.1016/j.jalz.2011.02.005. PubMed PMID: 21414553; PubMed Central PMCID: PMC Journal - In Process.
  147. Khan UA, Liu L, Provenzano FA, Berman DE, Profaci CP, Sloan R, et al. Molecular drivers and cortical spread of lateral entorhinal cortex dysfunction in preclinical Alzheimer's disease. Nature neuroscience. 2014;17(2):304-11. doi: 10.1038/nn.3606. PubMed PMID: 24362760; PubMed Central PMCID: PMC Journal - In Process.
  148. Klionsky DJ, Abdalla FC, Abeliovich H, Abraham RT, Acevedo-Arozena A, Adeli K, et al. Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy. 2012;8(4):445-544. PubMed PMID: 22966490; PubMed Central PMCID: PMC3404883.
  149. Krebs CE, Karkheiran S, Powell JC, Cao M, Makarov V, Darvish H, et al. The Sac1 domain of SYNJ1 identified mutated in a family with early-onset progressive Parkinsonism with generalized seizures. Hum Mutat. 2013;34(9):1200-7. doi: 10.1002/humu.22372. PubMed PMID: 23804563; PubMed Central PMCID: PMC3790461.
  150. Kuo SH, Erickson-Davis C, Gillman A, Faust PL, Vonsattel JP, Louis ED. Increased number of heterotopic Purkinje cells in essential tremor. Journal of neurology, neurosurgery, and psychiatry. 2011;82(9):1038-40. Epub 2010/08/31. doi: 10.1136/jnnp.2010.213330. PubMed PMID: 20802031; PubMed Central PMCID: PMC3856652.
  151. Kuo SH, Faust PL, Vonsattel JP, Ma K, Louis ED. Parallel fiber counts and parallel fiber integrated density are similar in essential tremor cases and controls. Acta Neuropathol. 2011;121(2):287-9. Epub 2010/11/17. doi: 10.1007/s00401-010-0776-9. PubMed PMID: 21080179; PubMed Central PMCID: PMC Journal - In Process.
  152. Kuo SH, Tang G, Louis ED, Ma K, Babji R, Balatbat M, et al. Lingo-1 expression is increased in essential tremor cerebellum and is present in the basket cell pinceau. Acta Neuropathol. 2013;125(6):879-89. doi: 10.1007/s00401-013-1108-7. PubMed PMID: 23543187; PubMed Central PMCID: PMC3663903.
  153. Kuo SH, Tang G, Ma K, Babij R, Cortes E, Vonsattel JP, et al. Macroautophagy abnormality in essential tremor. PloS one. 2012;7(12):e53040. doi: 10.1371/journal.pone.0053040. PubMed PMID: 23300858; PubMed Central PMCID: PMC3531444.
  154. Lane RF, Gatson JW, Small SA, Ehrlich ME, Gandy S. Protein kinase C and rho activated coiled coil protein kinase 2 (ROCK2) modulate Alzheimer's APP metabolism and phosphorylation of the Vps10-domain protein, SorL1. Mol Neurodegener. 2010;5:62. Epub 2011/01/05. doi: 1750-1326-5-62 [pii] 10.1186/1750-1326-5-62. PubMed PMID: 21192821; PubMed Central PMCID: PMC3036620.
  155. Lane RF, Raines SM, Steele JW, Ehrlich ME, Lah JA, Small SA, et al. Diabetes-associated SorCS1 regulates Alzheimer's amyloid-beta metabolism: evidence for involvement of SorL1 and the retromer complex. J Neurosci. 2010;30(39):13110-5. Epub 2010/10/01. doi: 30/39/13110 [pii] 10.1523/JNEUROSCI.3872-10.2010. PubMed PMID: 20881129; PubMed Central PMCID: PMC3274732.
  156. Lee JH, Cheng R, Barral S, Reitz C, Medrano M, Lantigua R, et al. Identification of novel loci for Alzheimer disease and replication of CLU, PICALM, and BIN1 in Caribbean Hispanic individuals. Archives of neurology. 2011;68(3):320-8. Epub 2010/11/10. doi: 10.1001/archneurol.2010.292. PubMed PMID: 21059989; PubMed Central PMCID: PMC3268783.
  157. Lee JH, Cheng R, Honig LS, Feitosa M, Kammerer CM, Kang MS, et al. Genome wide association and linkage analyses identified three loci-4q25, 17q23.2, and 10q11.21-associated with variation in leukocyte telomere length: the Long Life Family Study. Frontiers in genetics. 2013;4:310. doi: 10.3389/fgene.2013.00310. PubMed PMID: 24478790; PubMed Central PMCID: PMC3894567.
  158. Lee JH, Gurney S, Pang D, Temkin A, Park N, Janicki SC, et al. Polymorphisms in HSD17B1: Early Onset and Increased Risk of Alzheimer's Disease in Women with Down Syndrome. Curr Gerontol Geriatr Res. 2012;2012:361218. doi: 10.1155/2012/361218. PubMed PMID: 22474448; PubMed Central PMCID: PMC3310186.
  159. Lefort R, Pozueta J, Shelanski M. Cross-linking of cell surface amyloid precursor protein leads to increased beta-amyloid peptide production in hippocampal neurons: implications for Alzheimer's disease. J Neurosci. 2012;32(31):10674-85. doi: 10.1523/JNEUROSCI.6473-11.2012. PubMed PMID: 22855816; PubMed Central PMCID: PMC3539764.
  160. Lenderking WR, Wyrwich KW, Stolar M, Howard KA, Leibman C, Buchanan J, et al. Reliability, validity, and interpretation of the Dependence Scale in mild to moderately severe Alzheimer's disease. Am J Alzheimers Dis Other Demen. 2013;28(8):738-49. doi: 10.1177/1533317513504609. PubMed PMID: 24363071; PubMed Central PMCID: PMC Journal - In Process.
  161. Lewandowski NM, Bordelon Y, Brickman AM, Angulo S, Khan U, Muraskin J, et al. Regional vulnerability in Huntington's disease: fMRI-guided molecular analysis in patients and a mouse model of disease. Neurobiology of disease. 2013;52:84-93. doi: 10.1016/j.nbd.2012.11.014. PubMed PMID: 23220414; PubMed Central PMCID: PMC Journal - In Process.
  162. Lewandowski NM, Ju S, Verbitsky M, Ross B, Geddie ML, Rockenstein E, et al. Polyamine pathway contributes to the pathogenesis of Parkinson disease. Proc Natl Acad Sci U S A. 2010;107(39):16970-5. Epub 2010/09/15. doi: 1011751107 [pii] 10.1073/pnas.1011751107. PubMed PMID: 20837543; PubMed Central PMCID: PMC2947879.
  163. Litvan I, Goldman JG, Troster AI, Schmand BA, Weintraub D, Petersen RC, et al. Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines. Movement disorders : official journal of the Movement Disorder Society. 2012;27(3):349-56. Epub 2012/01/26. doi: 10.1002/mds.24893. PubMed PMID: 22275317; PubMed Central PMCID: PMC3641655.
  164. Liu L, Drouet V, Wu JW, Witter MP, Small SA, Clelland C, et al. Trans-synaptic spread of tau pathology in vivo. PloS one. 2012;7(2):e31302. doi: 10.1371/journal.pone.0031302. PubMed PMID: 22312444; PubMed Central PMCID: PMC3270029.
  165. Lloyd TE, Machamer J, O'Hara K, Kim JH, Collins SE, Wong MY, et al. The p150(Glued) CAP-Gly domain regulates initiation of retrograde transport at synaptic termini. Neuron. 2012;74(2):344-60. doi: 10.1016/j.neuron.2012.02.026. PubMed PMID: 22542187; PubMed Central PMCID: PMC3353876.
  166. Lotti F, Imlach WL, Saieva L, Beck ES, Hao le T, Li DK, et al. An SMN-dependent U12 splicing event essential for motor circuit function. Cell. 2012;151(2):440-54. doi: 10.1016/j.cell.2012.09.012. PubMed PMID: 23063131; PubMed Central PMCID: PMC3474596.
  167. Louis ED, Asabere N, Agnew A, Moskowitz CB, Lawton A, Cortes E, et al. Rest tremor in advanced essential tremor: a post-mortem study of nine cases. Journal of neurology, neurosurgery, and psychiatry. 2011;82(3):261-5. Epub 2010/08/31. doi: 10.1136/jnnp.2010.215681. PubMed PMID: 20802027; PubMed Central PMCID: PMC Journal - In Process.
  168. Louis ED, Babij R, Cortes E, Vonsattel JP, Faust PL. The inferior olivary nucleus: a postmortem study of essential tremor cases versus controls. Movement disorders : official journal of the Movement Disorder Society. 2013;28(6):779-86. doi: 10.1002/mds.25400. PubMed PMID: 23483605; PubMed Central PMCID: PMC3688649.
  169. Louis ED, Babij R, Lee M, Cortes E, Vonsattel JP. Quantification of cerebellar hemispheric purkinje cell linear density: 32 ET cases versus 16 controls. Movement disorders : official journal of the Movement Disorder Society. 2013;28(13):1854-9. doi: 10.1002/mds.25629. PubMed PMID: 23925732; PubMed Central PMCID: PMC3830681.
  170. Louis ED, Babij R, Ma K, Cortes E, Vonsattel JP. Essential tremor followed by progressive supranuclear palsy: postmortem reports of 11 patients. Journal of neuropathology and experimental neurology. 2013;72(1):8-17. doi: 10.1097/NEN.0b013e31827ae56e. PubMed PMID: 23242279; PubMed Central PMCID: PMC3530166.
  171. Louis ED, Erickson-Davis C, Pahwa R, Lyons KE, Garber A, Moskowitz CB, et al. Essential tremor with ubiquitinated Purkinje cell intranuclear inclusions. Acta Neuropathol. 2010;119(3):375-7. Epub 2010/01/29. doi: 10.1007/s00401-010-0641-x. PubMed PMID: 20107820; PubMed Central PMCID: PMC2857995.
  172. Louis ED, Faust PL, Ma KJ, Yu M, Cortes E, Vonsattel JP. Torpedoes in the cerebellar vermis in essential tremor cases vs. controls. Cerebellum. 2011;10(4):812-9. Epub 2011/06/10. doi: 10.1007/s12311-011-0291-0. PubMed PMID: 21656041; PubMed Central PMCID: PMC Journal - In Process.
  173. Louis ED, Faust PL, Vonsattel JP. Purkinje cell loss is a characteristic of essential tremor. Parkinsonism & related disorders. 2011;17(6):406-9. Epub 2011/05/24. doi: 10.1016/j.parkreldis.2011.05.004. PubMed PMID: 21600832; PubMed Central PMCID: PMC3119778.
  174. Louis ED, Faust PL, Vonsattel JP. Purkinje cell loss is a characteristic of essential tremor: towards a more mature understanding of pathogenesis. Parkinsonism & related disorders. 2012;18(8):1003-4. doi: 10.1016/j.parkreldis.2012.06.017. PubMed PMID: 22795481; PubMed Central PMCID: PMC Journal - In Process.
  175. Louis ED, Kuo SH, Vonsattel JP, Faust PL. Torpedo Formation and Purkinje Cell Loss: Modeling their Relationship in Cerebellar Disease. Cerebellum. 2014. doi: 10.1007/s12311-014-0556-5. PubMed PMID: 24590661; PubMed Central PMCID: PMC Journal - In Process.
  176. Louis ED, Ma K, Babij R, Cortes E, Liem RK, Vonsattel JP, et al. Neurofilament protein levels: quantitative analysis in essential tremor cerebellar cortex. Neuroscience letters. 2012;518(1):49-54. doi: 10.1016/j.neulet.2012.04.054. PubMed PMID: 22561033; PubMed Central PMCID: PMC3364538.
  177. Louis ED, Mazzoni P, Ma KJ, Moskowitz CB, Lawton A, Garber A, et al. Essential tremor with ubiquitinated intranuclear inclusions and cerebellar degeneration. Clinical neuropathology. 2012;31(3):119-26. PubMed PMID: 22551915; PubMed Central PMCID: PMC3636555.
  178. Luber B, Steffener J, Tucker A, Habeck C, Peterchev AV, Deng ZD, et al. Extended remediation of sleep deprived-induced working memory deficits using fMRI-guided transcranial magnetic stimulation. Sleep. 2013;36(6):857-71. doi: 10.5665/sleep.2712. PubMed PMID: 23729929; PubMed Central PMCID: PMC3649828.
  179. Luchsinger JA, Cheng D, Tang MX, Schupf N, Mayeux R. Central obesity in the elderly is related to late-onset Alzheimer disease. Alzheimer disease and associated disorders. 2012;26(2):101-5. doi: 10.1097/WAD.0b013e318222f0d4. PubMed PMID: 21666429; PubMed Central PMCID: PMC3358415.
  180. Ma K, Babij R, Cortes E, Vonsattel JP, Louis ED. Cerebellar Pathology of a Dual Clinical Diagnosis: Patients with Essential Tremor and Dystonia. Tremor and other hyperkinetic movements. 2012;2. PubMed PMID: 23293750; PubMed Central PMCID: PMC3535836.
  181. MacLeod DA, Rhinn H, Kuwahara T, Zolin A, Di Paolo G, McCabe BD, et al. RAB7L1 interacts with LRRK2 to modify intraneuronal protein sorting and Parkinson's disease risk. Neuron. 2013;77(3):425-39. doi: 10.1016/j.neuron.2012.11.033. PubMed PMID: 23395371; PubMed Central PMCID: PMC3646583.
  182. Manly JJ, Schupf N, Stern Y, Brickman AM, Tang MX, Mayeux R. Telephone-based identification of mild cognitive impairment and dementia in a multicultural cohort. Archives of neurology. 2011;68(5):607-14. Epub 2011/05/11. doi: 10.1001/archneurol.2011.88. PubMed PMID: 21555635; PubMed Central PMCID: PMC3102767.
  183. Manoochehri M, Huey ED. Diagnosis and management of behavioral issues in frontotemporal dementia. Current neurology and neuroscience reports. 2012;12(5):528-36. doi: 10.1007/s11910-012-0302-7. PubMed PMID: 22847063; PubMed Central PMCID: PMC3443960.
  184. Marder K. Tarenflurbil in patients with mild Alzheimer's disease. Current neurology and neuroscience reports. 2010;10(5):336-7. Epub 2010/06/24. doi: 10.1007/s11910-010-0130-6. PubMed PMID: 20571933; PubMed Central PMCID: PMC Journal - In Process.
  185. Marder K. Cognitive impairment and dementia in Parkinson's disease. Movement disorders : official journal of the Movement Disorder Society. 2010;25 Suppl 1:S110-6. Epub 2010/02/27. doi: 10.1002/mds.22787. PubMed PMID: 20187235; PubMed Central PMCID: PMC Journal - In Process.
  186. Mayeux R. Clinical practice. Early Alzheimer's disease. N Engl J Med. 2010;362(23):2194-201. Epub 2010/06/19. doi: 362/23/2194 [pii] 10.1056/NEJMcp0910236. PubMed PMID: 20558370; PubMed Central PMCID: PMC Journal - In Process.
  187. Mayeux R, Reitz C, Brickman AM, Haan MN, Manly JJ, Glymour MM, et al. Operationalizing diagnostic criteria for Alzheimer's disease and other age-related cognitive impairment-Part 1. Alzheimers Dement. 2011;7(1):15-34. Epub 2011/01/25. doi: 10.1016/j.jalz.2010.11.005. PubMed PMID: 21255741; PubMed Central PMCID: PMC3063444.
  188. Mayeux R, Schupf N. Blood-based biomarkers for Alzheimer's disease: plasma Abeta40 and Abeta42, and genetic variants. Neurobiology of aging. 2011;32 Suppl 1:S10-9. Epub 2011/12/07. doi: 10.1016/j.neurobiolaging.2011.09.004. PubMed PMID: 22078169; PubMed Central PMCID: PMC3233700.
  189. Mayeux R, Stern Y. Epidemiology of Alzheimer disease. Cold Spring Harb Perspect Med. 2012;2(8). doi: 10.1101/cshperspect.a006239. PubMed PMID: 22908189; PubMed Central PMCID: PMC3339565.
  190. McGuire V, Van Den Eeden SK, Tanner CM, Kamel F, Umbach DM, Marder K, et al. Association of DRD2 and DRD3 polymorphisms with Parkinson's disease in a multiethnic consortium. J Neurol Sci. 2011;307(1-2):22-9. Epub 2011/06/15. doi: 10.1016/j.jns.2011.05.031. PubMed PMID: 21663922; PubMed Central PMCID: PMC3155471.
  191. McIntire LB, Berman DE, Myaeng J, Staniszewski A, Arancio O, Di Paolo G, et al. Reduction of synaptojanin 1 ameliorates synaptic and behavioral impairments in a mouse model of Alzheimer's disease. J Neurosci. 2012;32(44):15271-6. doi: 10.1523/JNEUROSCI.2034-12.2012. PubMed PMID: 23115165; PubMed Central PMCID: PMC3711720.
  192. McIntire LB, Lee KI, Chang-Ileto B, Di Paolo G, Kim TW. Screening assay for small-molecule inhibitors of synaptojanin 1, a synaptic phosphoinositide phosphatase. J Biomol Screen. 2014;19(4):585-94. doi: 10.1177/1087057113510177. PubMed PMID: 24186361; PubMed Central PMCID: PMC Journal - In Process.
  193. McKhann G, Mayeux R. Brain drain: A bottom-up approach to normal pressure hydrocephalus. Annals of neurology. 2010;68(4):415-7. Epub 2010/10/27. doi: 10.1002/ana.22212. PubMed PMID: 20976762; PubMed Central PMCID: PMC Journal - In Process.
  194. McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack CR, Jr., Kawas CH, et al. The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement. 2011;7(3):263-9. Epub 2011/04/26. doi: 10.1016/j.jalz.2011.03.005. PubMed PMID: 21514250; PubMed Central PMCID: PMC3312024.
  195. McLaughlin T, Feldman H, Fillit H, Sano M, Schmitt F, Aisen P, et al. Dependence as a unifying construct in defining Alzheimer's disease severity. Alzheimers Dement. 2010;6(6):482-93. Epub 2010/11/04. doi: S1552-5260(09)02328-0 [pii] 10.1016/j.jalz.2009.09.004. PubMed PMID: 21044778; PubMed Central PMCID: PMC3884683.
  196. Mecozzi VJ, Berman DE, Simoes S, Vetanovetz C, Awal MR, Patel VM, et al. Pharmacological chaperones stabilize retromer to limit APP processing. Nature chemical biology. 2014. doi: 10.1038/nchembio.1508. PubMed PMID: 24747528.
  197. Meier IB, Manly JJ, Provenzano FA, Louie KS, Wasserman BT, Griffith EY, et al. White Matter Predictors of Cognitive Functioning in Older Adults. J Int Neuropsychol Soc. 2012:1-14. Epub 2012/03/07. doi: 10.1017/S1355617712000227. PubMed PMID: 22390883; PubMed Central PMCID: PMC3565460.
  198. Meoded A, Kwan JY, Peters TL, Huey ED, Danielian LE, Wiggs E, et al. Imaging findings associated with cognitive performance in primary lateral sclerosis and amyotrophic lateral sclerosis. Dement Geriatr Cogn Dis Extra. 2013;3(1):233-50. doi: 10.1159/000353456. PubMed PMID: 24052798; PubMed Central PMCID: PMC3776403.
  199. Metcalfe J, Butterfield B, Habeck C, Stern Y. Neural correlates of people's hypercorrection of their false beliefs. Journal of cognitive neuroscience. 2012;24(7):1571-83. doi: 10.1162/jocn_a_00228. PubMed PMID: 22452558; PubMed Central PMCID: PMC3970786.
  200. Mez J, Cosentino S, Brickman AM, Huey ED, Manly JJ, Mayeux R. Dysexecutive versus amnestic Alzheimer disease subgroups: analysis of demographic, genetic, and vascular factors. Alzheimer disease and associated disorders. 2013;27(3):218-25. doi: 10.1097/WAD.0b013e31826a94bd. PubMed PMID: 23954887; PubMed Central PMCID: PMC3748394.
  201. Mez J, Cosentino S, Brickman AM, Huey ED, Manly JJ, Mayeux R. Faster cognitive and functional decline in Dysexecutive versus amnestic Alzheimer's subgroups: a longitudinal analysis of the National Alzheimer's Coordinating Center (NACC) database. PloS one. 2013;8(6):e65246. doi: 10.1371/journal.pone.0065246. PubMed PMID: 23755200; PubMed Central PMCID: PMC3670903.
  202. Mez J, Cosentino S, Brickman AM, Huey ED, Mayeux R. Different demographic, genetic, and longitudinal traits in language versus memory Alzheimer's subgroups. Journal of Alzheimer's disease : JAD. 2013;37(1):137-46. doi: 10.3233/JAD-130320. PubMed PMID: 23788008; PubMed Central PMCID: PMC3877683.
  203. Mills SM, Mallmann J, Santacruz AM, Fuqua A, Carril M, Aisen PS, et al. Preclinical trials in autosomal dominant AD: implementation of the DIAN-TU trial. Rev Neurol (Paris). 2013;169(10):737-43. doi: 10.1016/j.neurol.2013.07.017. PubMed PMID: 24016464; PubMed Central PMCID: PMC3880800.
  204. Miyashita A, Koike A, Jun G, Wang LS, Takahashi S, Matsubara E, et al. SORL1 is genetically associated with late-onset Alzheimer's disease in Japanese, Koreans and Caucasians. PloS one. 2013;8(4):e58618. doi: 10.1371/journal.pone.0058618. PubMed PMID: 23565137; PubMed Central PMCID: PMC3614978.
  205. Mollenhauer B, Trautmann E, Otte B, Ng J, Spreer A, Lange P, et al. alpha-Synuclein in human cerebrospinal fluid is principally derived from neurons of the central nervous system. J Neural Transm. 2012;119(7):739-46. doi: 10.1007/s00702-012-0784-0. PubMed PMID: 22426833; PubMed Central PMCID: PMC3378837.
  206. Morabito MV, Berman DE, Schneider RT, Zhang Y, Leibel RL, Small SA. Hyperleucinemia causes hippocampal retromer deficiency linking diabetes to Alzheimer's disease. Neurobiology of disease. 2014;65C:188-92. doi: 10.1016/j.nbd.2013.12.017. PubMed PMID: 24440570; PubMed Central PMCID: PMC Journal - In Process.
  207. Morel E, Chamoun Z, Lasiecka ZM, Chan RB, Williamson RL, Vetanovetz C, et al. Phosphatidylinositol-3-phosphate regulates sorting and processing of amyloid precursor protein through the endosomal system. Nature communications. 2013;4:2250. doi: 10.1038/ncomms3250. PubMed PMID: 23907271; PubMed Central PMCID: PMC3905799.
  208. Morris JC, Aisen PS, Bateman RJ, Benzinger TL, Cairns NJ, Fagan AM, et al. Developing an international network for Alzheimer research: The Dominantly Inherited Alzheimer Network. Clin Investig (Lond). 2012;2(10):975-84. doi: 10.4155/cli.12.93. PubMed PMID: 23139856; PubMed Central PMCID: PMC3489185.
  209. Muller M, Schupf N, Manly JJ, Mayeux R, Luchsinger JA. Sex hormone binding globulin and incident Alzheimer's disease in elderly men and women. Neurobiology of aging. 2010;31(10):1758-65. Epub 2008/11/22. doi: S0197-4580(08)00361-8 [pii] 10.1016/j.neurobiolaging.2008.10.001. PubMed PMID: 19022535; PubMed Central PMCID: PMC2891653.
  210. Naj AC, Jun G, Beecham GW, Wang LS, Vardarajan BN, Buros J, et al. Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease. Nat Genet. 2011;43(5):436-41. Epub 2011/04/05. doi: 10.1038/ng.801. PubMed PMID: 21460841; PubMed Central PMCID: PMC3090745.
  211. Nalls MA, Duran R, Lopez G, Kurzawa-Akanbi M, McKeith IG, Chinnery PF, et al. A multicenter study of glucocerebrosidase mutations in dementia with Lewy bodies. JAMA neurology. 2013;70(6):727-35. doi: 10.1001/jamaneurol.2013.1925. PubMed PMID: 23588557; PubMed Central PMCID: PMC3841974.
  212. Naylor MD, Karlawish JH, Arnold SE, Khachaturian AS, Khachaturian ZS, Lee VM, et al. Advancing Alzheimer's disease diagnosis, treatment, and care: recommendations from the Ware Invitational Summit. Alzheimers Dement. 2012;8(5):445-52. doi: 10.1016/j.jalz.2012.08.001. PubMed PMID: 22959699; PubMed Central PMCID: PMC3552530.
  213. Nervi A, Reitz C, Tang MX, Santana V, Piriz A, Reyes D, et al. Familial aggregation of dementia with Lewy bodies. Archives of neurology. 2011;68(1):90-3. Epub 2011/01/12. doi: 10.1001/archneurol.2010.319. PubMed PMID: 21220678; PubMed Central PMCID: PMC3268781.
  214. Noble JM. Dementia and Memory Loss: Parkinson's Disease Dementia and Dementia with Lewy Bodies. In: Brust J, editor. Current Diagnosis and Treatment in Neurology. 2nd ed. New York, NY: McGraw Hill-Medical; 2011. p. 92-6.
  215. Noble JM, Manly JJ, Schupf N, Tang MX, Luchsinger JA. Type 2 diabetes and ethnic disparities in cognitive impairment. Ethn Dis. 2012;22(1):38-44. PubMed PMID: 22774307; PubMed Central PMCID: PMC3398739.
  216. Noble JM, Manly JJ, Schupf N, Tang MX, Mayeux R, Luchsinger JA. Association of C-reactive protein with cognitive impairment. Archives of neurology. 2010;67(1):87-92. Epub 2010/01/13. doi: 67/1/87 [pii] 10.1001/archneurol.2009.308. PubMed PMID: 20065134; PubMed Central PMCID: PMC Journal - In Process.
  217. Nuytemans K, Inchausti V, Beecham GW, Wang L, Dickson DW, Trojanowski JQ, et al. Absence of C9ORF72 expanded or intermediate repeats in autopsy-confirmed Parkinson's disease. Movement disorders : official journal of the Movement Disorder Society. 2014. doi: 10.1002/mds.25838. PubMed PMID: 24573903; PubMed Central PMCID: PMC Journal - In Process.
  218. Okada H, Zhang W, Peterhoff C, Hwang JC, Nixon RA, Ryu SH, et al. Proteomic identification of sorting nexin 6 as a negative regulator of BACE1-mediated APP processing. FASEB J. 2010;24(8):2783-94. Epub 2010/04/01. doi: fj.09-146357 [pii] 10.1096/fj.09-146357 [doi]. PubMed PMID: 20354142; PubMed Central PMCID: PMC2909280.
  219. Oliveira TG, Chan RB, Tian H, Laredo M, Shui G, Staniszewski A, et al. Phospholipase d2 ablation ameliorates Alzheimer's disease-linked synaptic dysfunction and cognitive deficits. J Neurosci. 2010;30(49):16419-28. Epub 2010/12/15. doi: 30/49/16419 [pii] 10.1523/JNEUROSCI.3317-10.2010 [doi]. PubMed PMID: 21147981; PubMed Central PMCID: PMC3004537.
  220. Onyike CU, Huey ED. Frontotemporal dementia and psychiatry. International review of psychiatry. 2013;25(2):127-9. doi: 10.3109/09540261.2013.785169. PubMed PMID: 23611342; PubMed Central PMCID: PMC3947598.
  221. Orenstein SJ, Kuo SH, Tasset I, Arias E, Koga H, Fernandez-Carasa I, et al. Interplay of LRRK2 with chaperone-mediated autophagy. Nature neuroscience. 2013. doi: 10.1038/nn.3350. PubMed PMID: 23455607; PubMed Central PMCID: PMC3609872.
  222. Ornstein K, Gaugler JE, Devanand DP, Scarmeas N, Zhu C, Stern Y. The differential impact of unique behavioral and psychological symptoms for the dementia caregiver: how and why do patients' individual symptom clusters impact caregiver depressive symptoms? Am J Geriatr Psychiatry. 2013;21(12):1277-86. doi: 10.1016/j.jagp.2013.01.062 10.1097/JGP.0b013e31826d6b31. PubMed PMID: 24206939; PubMed Central PMCID: PMC3543497.
  223. Ornstein KA, Gaugler JE, Devanand DP, Scarmeas N, Zhu CW, Stern Y. Are there sensitive time periods for dementia caregivers? The occurrence of behavioral and psychological symptoms in the early stages of dementia. Int Psychogeriatr. 2013;25(9):1453-62. doi: 10.1017/S1041610213000768. PubMed PMID: 23725657; PubMed Central PMCID: PMC3758760.
  224. Pankratz N, Beecham GW, DeStefano AL, Dawson TM, Doheny KF, Factor SA, et al. Meta-analysis of Parkinson's disease: identification of a novel locus, RIT2. Annals of neurology. 2012;71(3):370-84. doi: 10.1002/ana.22687. PubMed PMID: 22451204; PubMed Central PMCID: PMC3354734.
  225. Pavlopoulos E, Jones S, Kosmidis S, Close M, Kim C, Kovalerchik O, et al. Molecular mechanism for age-related memory loss: the histone-binding protein RbAp48. Science translational medicine. 2013;5(200):200ra115. doi: 10.1126/scitranslmed.3006373. PubMed PMID: 23986399; PubMed Central PMCID: PMC Journal - In Process.
  226. Pelton GH, Andrews H, Roose SP, Marcus SM, D'Antonio K, Husn H, et al. Donepezil treatment of older adults with cognitive impairment and depression (DOTCODE study): Clinical rationale and design. Contemp Clin Trials. 2013;37(2):200-8. doi: 10.1016/j.cct.2013.11.015. PubMed PMID: 24315979; PubMed Central PMCID: PMC3981878.
  227. Pianu B, Lefort R, Thuiliere L, Tabourier E, Bartolini F. The Abeta(1)(-)(4)(2) peptide regulates microtubule stability independently of tau. Journal of cell science. 2014;127(Pt 5):1117-27. doi: 10.1242/jcs.143750. PubMed PMID: 24424028.
  228. Pizzo AB, Karam CS, Zhang Y, Ma CL, McCabe BD, Javitch JA. Amphetamine-induced behavior requires CaMKII-dependent dopamine transporter phosphorylation. Molecular psychiatry. 2014;19(3):279-81. doi: 10.1038/mp.2013.29. PubMed PMID: 23508128.
  229. Pizzo AB, Karam CS, Zhang Y, Yano H, Freyberg RJ, Karam DS, et al. The membrane raft protein Flotillin-1 is essential in dopamine neurons for amphetamine-induced behavior in Drosophila. Molecular psychiatry. 2012. doi: 10.1038/mp.2012.82. PubMed PMID: 22710269; PubMed Central PMCID: PMC3582826.
  230. Porsteinsson AP, Drye LT, Pollock BG, Devanand DP, Frangakis C, Ismail Z, et al. Effect of citalopram on agitation in Alzheimer disease: the CitAD randomized clinical trial. JAMA : the journal of the American Medical Association. 2014;311(7):682-91. doi: 10.1001/jama.2014.93. PubMed PMID: 24549548; PubMed Central PMCID: PMC Journal - In Process.
  231. Posner HB, Cano S, Carrillo MC, Selnes O, Stern Y, Thomas RG, et al. Establishing the psychometric underpinning of cognition measures for clinical trials of Alzheimer's disease and its precursors: a new approach. Alzheimers Dement. 2013;9(1 Suppl):S56-60. doi: 10.1016/j.jalz.2012.10.008. PubMed PMID: 23391006; PubMed Central PMCID: PMC Journal - In Process.
  232. Poulopoulos M, Cortes E, Vonsattel JP, Fahn S, Waters C, Cote LJ, et al. Clinical and pathological characteristics of LRRK2 G2019S patients with PD. J Mol Neurosci. 2012;47(1):139-43. doi: 10.1007/s12031-011-9696-y. PubMed PMID: 22194196; PubMed Central PMCID: PMC3335886.
  233. Pozueta J, Lefort R, Ribe EM, Troy CM, Arancio O, Shelanski M. Caspase-2 is required for dendritic spine and behavioural alterations in J20 APP transgenic mice. Nature communications. 2013;4:1939. doi: 10.1038/ncomms2927. PubMed PMID: 23748737.
  234. Pozueta J, Lefort R, Shelanski ML. Synaptic changes in Alzheimer's disease and its models. Neuroscience. 2012. doi: 10.1016/j.neuroscience.2012.05.050. PubMed PMID: 22687952; PubMed Central PMCID: PMC Journal - In Process.
  235. Price CC, Cunningham H, Coronado N, Freedland A, Cosentino S, Penney DL, et al. Clock Drawing in the Montreal Cognitive Assessment: Recommendations for Dementia Assessment. Dement Geriatr Cogn Disord. 2011;31(3):179-87. Epub 2011/03/11. doi: 000324639 [pii] 10.1159/000324639. PubMed PMID: 21389719; PubMed Central PMCID: PMC3065510.
  236. Razlighi QR, Stallard E, Brandt J, Blacker D, Albert M, Scarmeas N, et al. A new algorithm for predicting time to disease endpoints in Alzheimer's disease patients. Journal of Alzheimer's disease : JAD. 2014;38(3):661-8. doi: 10.3233/JAD-131142. PubMed PMID: 24064468; PubMed Central PMCID: PMC3864687.
  237. Razlighi QR, Steffener J, Habeck C, Laine A, Stern Y. Resting state inter and intra hemispheric human brain functional connectivity. Conf Proc IEEE Eng Med Biol Soc. 2013;2013:6522-5. doi: 10.1109/EMBC.2013.6611049. PubMed PMID: 24111236; PubMed Central PMCID: PMC3966302.
  238. Reitz C. Dyslipidemia and dementia: current epidemiology, genetic evidence, and mechanisms behind the associations. Journal of Alzheimer's disease : JAD. 2012;30 Suppl 2:S127-45. doi: 10.3233/JAD-2011-110599. PubMed PMID: 21965313; PubMed Central PMCID: PMC3689537.
  239. Reitz C, Brayne C, Mayeux R. Epidemiology of Alzheimer disease. Nat Rev Neurol. 2011;7(3):137-52. Epub 2011/02/10. doi: 10.1038/nrneurol.2011.2. PubMed PMID: 21304480; PubMed Central PMCID: PMC3339565.
  240. Reitz C, Cheng R, Rogaeva E, Lee JH, Tokuhiro S, Zou F, et al. Meta-analysis of the association between variants in SORL1 and Alzheimer disease. Archives of neurology. 2011;68(1):99-106. Epub 2011/01/12. doi: 10.1001/archneurol.2010.346. PubMed PMID: 21220680; PubMed Central PMCID: PMC3086666.
  241. Reitz C, Cheng R, Schupf N, Lee JH, Mehta PD, Rogaeva E, et al. Association between variants in IDE-KIF11-HHEX and plasma amyloid beta levels. Neurobiology of aging. 2010. Epub 2010/08/21. doi: S0197-4580(10)00312-X [pii]10.1016/j.neurobiolaging.2010.07.005. PubMed PMID: 20724036; PubMed Central PMCID: PMC3117070.
  242. Reitz C, Conrad C, Roszkowski K, Rogers RS, Mayeux R. Effect of genetic variation in LRRTM3 on risk of Alzheimer disease. Archives of neurology. 2012;69(7):894-900. doi: 10.1001/archneurol.2011.2463. PubMed PMID: 22393166; PubMed Central PMCID: PMC3391336.
  243. Reitz C, Jun G, Naj A, Rajbhandary R, Vardarajan BN, Wang LS, et al. Variants in the ATP-binding cassette transporter (ABCA7), apolipoprotein E 4,and the risk of late-onset Alzheimer disease in African Americans. JAMA : the journal of the American Medical Association. 2013;309(14):1483-92. doi: 10.1001/jama.2013.2973. PubMed PMID: 23571587; PubMed Central PMCID: PMC3667653.
  244. Reitz C, Lee JH, Rogers RS, Mayeux R. Impact of genetic variation in SORCS1 on memory retention. PloS one. 2011;6(10):e24588. Epub 2011/11/03. doi: 10.1371/journal.pone.0024588. PubMed PMID: 22046233; PubMed Central PMCID: PMC3202519.
  245. Reitz C, Mayeux R. Use of genetic variation as biomarkers for mild cognitive impairment and progression of mild cognitive impairment to dementia. Journal of Alzheimer's disease : JAD. 2010;19(1):229-51. Epub 2010/01/12. doi: N0R335VT02G24721 [pii]10.3233/JAD-2010-1255. PubMed PMID: 20061642; PubMed Central PMCID: PMC2908485.
  246. Reitz C, Mayeux R. Genetics of Alzheimer's Disease in Caribbean Hispanic and African American Populations. Biological psychiatry. 2013. doi: 10.1016/j.biopsych.2013.06.003. PubMed PMID: 23890735; PubMed Central PMCID: PMC3902050.
  247. Reitz C, Mayeux R. Alzheimer disease: Epidemiology, diagnostic criteria, risk factors and biomarkers. Biochem Pharmacol. 2014. doi: 10.1016/j.bcp.2013.12.024. PubMed PMID: 24398425; PubMed Central PMCID: PMC Journal - In Process.
  248. Reitz C, Mayeux R, Alzheimer's Disease Genetics C. TREM2 and neurodegenerative disease. N Engl J Med. 2013;369(16):1564-5. doi: 10.1056/NEJMc1306509#SA1. PubMed PMID: 24131184; PubMed Central PMCID: PMC3980568.
  249. Reitz C, Tang MX, Schupf N, Manly JJ, Mayeux R, Luchsinger JA. A summary risk score for the prediction of Alzheimer disease in elderly persons. Archives of neurology. 2010;67(7):835-41. Epub 2010/07/14. doi: 67/7/835 [pii]10.1001/archneurol.2010.136. PubMed PMID: 20625090; PubMed Central PMCID: PMC3068839.
  250. Reitz C, Tang MX, Schupf N, Manly JJ, Mayeux R, Luchsinger JA. Association of higher levels of high-density lipoprotein cholesterol in elderly individuals and lower risk of late-onset Alzheimer disease. Archives of neurology. 2010;67(12):1491-7. Epub 2010/12/15. doi: 67/12/1491 [pii] 10.1001/archneurol.2010.297. PubMed PMID: 21149810; PubMed Central PMCID: PMC3065942.
  251. Reitz C, Tokuhiro S, Clark LN, Conrad C, Vonsattel JP, Hazrati LN, et al. SORCS1 alters amyloid precursor protein processing and variants may increase Alzheimer's disease risk. Annals of neurology. 2011;69(1):47-64. Epub 2011/02/01. doi: 10.1002/ana.22308. PubMed PMID: 21280075; PubMed Central PMCID: PMC3086759.
  252. Reitz C, Tosto G, Mayeux R, Luchsinger JA, Group N-LNFS, Alzheimer's Disease Neuroimaging I. Genetic variants in the Fat and Obesity Associated (FTO) gene and risk of Alzheimer's disease. PloS one. 2012;7(12):e50354. doi: 10.1371/journal.pone.0050354. PubMed PMID: 23251365; PubMed Central PMCID: PMC3520931.
  253. Reitz C, Tosto G, Vardarajan B, Rogaeva E, Ghani M, Rogers RS, et al. Independent and epistatic effects of variants in VPS10-d receptors on Alzheimer disease risk and processing of the amyloid precursor protein (APP). Translational psychiatry. 2013;3:e256. doi: 10.1038/tp.2013.13. PubMed PMID: 23673467; PubMed Central PMCID: PMC3669917.
  254. Rentz DM, Parra Rodriguez MA, Amariglio R, Stern Y, Sperling R, Ferris S. Promising developments in neuropsychological approaches for the detection of preclinical Alzheimer's disease: a selective review. Alzheimers Res Ther. 2013;5(6):58. doi: 10.1186/alzrt222. PubMed PMID: 24257331; PubMed Central PMCID: PMC Journal - In Process.
  255. Reuben A, Brickman AM, Muraskin J, Steffener J, Stern Y. Hippocampal atrophy relates to fluid intelligence decline in the elderly. J Int Neuropsychol Soc. 2011;17(1):56-61. Epub 2010/11/26. doi: 10.1017/S135561771000127X. PubMed PMID: 21092387; PubMed Central PMCID: PMC3785543.
  256. Richard E, Reitz C, Honig LH, Schupf N, Tang MX, Manly JJ, et al. Late-life depression, mild cognitive impairment, and dementia. JAMA neurology. 2013;70(3):374-82. doi: 10.1001/jamaneurol.2013.603. PubMed PMID: 23599941; PubMed Central PMCID: PMC3694613.
  257. Rivera Mindt M, Byrd D, Saez P, Manly J. Increasing culturally competent neuropsychological services for ethnic minority populations: a call to action. Clin Neuropsychol. 2010;24(3):429-53. Epub 2010/04/08. doi: 920951034 [pii] 10.1080/13854040903058960 [doi]. PubMed PMID: 20373222; PubMed Central PMCID: PMC2909768.
  258. Roach AN, Wang Z, Wu P, Zhang F, Chan RB, Yonekubo Y, et al. Phosphatidic acid regulation of PIPKI is critical for actin cytoskeletal reorganization. J Lipid Res. 2012;53(12):2598-609. doi: 10.1194/jlr.M028597. PubMed PMID: 22991193; PubMed Central PMCID: PMC3494241.
  259. Rodriguez-Navarro JA, Kaushik S, Koga H, Dall'Armi C, Shui G, Wenk MR, et al. Inhibitory effect of dietary lipids on chaperone-mediated autophagy. Proc Natl Acad Sci U S A. 2012;109(12):E705-14. doi: 10.1073/pnas.1113036109. PubMed PMID: 22331875; PubMed Central PMCID: PMC3311383.
  260. Rub U, Hoche F, Brunt ER, Heinsen H, Seidel K, Del Turco D, et al. Degeneration of the Cerebellum in Huntington's Disease (HD): Possible Relevance for the Clinical Picture and Potential Gateway to Pathological Mechanisms of the Disease Process. Brain pathology. 2013;23(2):165-77. doi: 10.1111/j.1750-3639.2012.00629.x. PubMed PMID: 22925167; PubMed Central PMCID: PMC Journal - In Process.
  261. Sachdev PS, Lipnicki DM, Kochan NA, Crawford JD, Rockwood K, Xiao S, et al. COSMIC (Cohort Studies of Memory in an International Consortium): an international consortium to identify risk and protective factors and biomarkers of cognitive ageing and dementia in diverse ethnic and sociocultural groups. BMC Neurol. 2013;13:165. doi: 10.1186/1471-2377-13-165. PubMed PMID: 24195705; PubMed Central PMCID: PMC3827845.
  262. Salloway S, Sperling R, Fox NC, Blennow K, Klunk W, Raskind M, et al. Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease. N Engl J Med. 2014;370(4):322-33. doi: 10.1056/NEJMoa1304839. PubMed PMID: 24450891; PubMed Central PMCID: PMC Journal - In Process.
  263. Sano M, Bell KL, Galasko D, Galvin JE, Thomas RG, van Dyck CH, et al. A randomized, double-blind, placebo-controlled trial of simvastatin to treat Alzheimer disease. Neurology. 2011;77(6):556-63. Epub 2011/07/29. doi: 10.1212/WNL.0b013e318228bf11. PubMed PMID: 21795660; PubMed Central PMCID: PMC3149154.
  264. Santa-Maria I, Haggiagi A, Liu X, Wasserscheid J, Nelson PT, Dewar K, et al. The MAPT H1 haplotype is associated with tangle-predominant dementia. Acta Neuropathol. 2012;124(5):693-704. doi: 10.1007/s00401-012-1017-1. PubMed PMID: 22802095; PubMed Central PMCID: PMC3608475.
  265. Sapp E, Valencia A, Li X, Aronin N, Kegel KB, Vonsattel JP, et al. Native mutant huntingtin in human brain: evidence for prevalence of full-length monomer. The Journal of biological chemistry. 2012;287(16):13487-99. doi: 10.1074/jbc.M111.286609. PubMed PMID: 22375012; PubMed Central PMCID: PMC3339996.
  266. Scarmeas N, Luchsinger JA, Brickman AM, Cosentino S, Schupf N, Xin-Tang M, et al. Physical activity and Alzheimer disease course. Am J Geriatr Psychiatry. 2011;19(5):471-81. Epub 2010/09/03. doi: 10.1097/JGP.0b013e3181eb00a9. PubMed PMID: 20808142; PubMed Central PMCID: PMC2998555.
  267. Scarmeas N, Luchsinger JA, Stern Y, Gu Y, He J, DeCarli C, et al. Mediterranean diet and magnetic resonance imaging-assessed cerebrovascular disease. Annals of neurology. 2011;69(2):257-68. Epub 2011/03/10. doi: 10.1002/ana.22317. PubMed PMID: 21387371; PubMed Central PMCID: PMC3066080.
  268. Schobel SA, Chaudhury NH, Khan UA, Paniagua B, Styner MA, Asllani I, et al. Imaging patients with psychosis and a mouse model establishes a spreading pattern of hippocampal dysfunction and implicates glutamate as a driver. Neuron. 2013;78(1):81-93. doi: 10.1016/j.neuron.2013.02.011. PubMed PMID: 23583108; PubMed Central PMCID: PMC3966570.
  269. Schupf N, Barral S, Perls T, Newman A, Christensen K, Thyagarajan B, et al. Apolipoprotein E and familial longevity. Neurobiology of aging. 2013;34(4):1287-91. doi: 10.1016/j.neurobiolaging.2012.08.019. PubMed PMID: 23040522; PubMed Central PMCID: PMC3545094.
  270. Schupf N, Zigman WB, Tang MX, Pang D, Mayeux R, Mehta P, et al. Change in plasma AB peptides and onset of dementia in adults with Down syndrome. Neurology. 2010;75(18):1639-44. Epub 2010/11/03. doi: 75/18/1639 [pii] 10.1212/WNL.0b013e3181fb448b. PubMed PMID: 21041786; PubMed Central PMCID: PMC3385463.
  271. Shamy JL, Habeck C, Hof PR, Amaral DG, Fong SG, Buonocore MH, et al. Volumetric correlates of spatiotemporal working and recognition memory impairment in aged rhesus monkeys. Cereb Cortex. 2011;21(7):1559-73. Epub 2010/12/04. doi: 10.1093/cercor/bhq210. PubMed PMID: 21127015; PubMed Central PMCID: PMC3116736.
  272. Sharp ME, Marder KS, Cote L, Clark LN, Nichols WC, Vonsattel JP, et al. Parkinson's disease with Lewy bodies associated with a heterozygous PARKIN dosage mutation. Movement disorders : official journal of the Movement Disorder Society. 2013. doi: 10.1002/mds.25792. PubMed PMID: 24375549; PubMed Central PMCID: PMC Journal - In Process.
  273. Sherman AV, Gubitz AK, Al-Chalabi A, Bedlack R, Berry J, Conwit R, et al. Infrastructure resources for clinical research in amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener. 2013;14 Suppl 1:53-61. doi: 10.3109/21678421.2013.779058. PubMed PMID: 23678880; PubMed Central PMCID: PMC Journal - In Process.
  274. Siedlecki KL, Manly JJ, Brickman AM, Schupf N, Tang MX, Stern Y. Do neuropsychological tests have the same meaning in Spanish speakers as they do in English speakers? Neuropsychology. 2010;24(3):402-11. Epub 2010/05/05. doi: 2010-07896-012 [pii] 10.1037/a0017515. PubMed PMID: 20438217; PubMed Central PMCID: PMC3908788.
  275. Siedlecki KL, Rundek T, Elkind MS, Sacco RL, Stern Y, Wright CB. Using contextual analyses to examine the meaning of neuropsychological variables across samples of english-speaking and spanish-speaking older adults. J Int Neuropsychol Soc. 2012;18(2):223-33. doi: 10.1017/S135561771100155X. PubMed PMID: 22182463; PubMed Central PMCID: PMC3370823.
  276. Small SA. Neurobiological correlates of imaging. Network. 2011;22(1-4):162-72. Epub 2011/12/14. doi: 10.3109/0954898X.2011.638695. PubMed PMID: 22149677; PubMed Central PMCID: PMC Journal - In Process.
  277. Small SA, Schobel SA, Buxton RB, Witter MP, Barnes CA. A pathophysiological framework of hippocampal dysfunction in ageing and disease. Nature reviews Neuroscience. 2011;12(10):585-601. Epub 2011/09/08. doi: 10.1038/nrn3085. PubMed PMID: 21897434; PubMed Central PMCID: PMC3312472.
  278. Soldan A, Habeck C, Gazes Y, Stern Y. Neural mechanisms of repetition priming of familiar and globally unfamiliar visual objects. Brain Res. 2010;1343:122-34. Epub 2010/05/11. doi: S0006-8993(10)01007-3 [pii] 10.1016/j.brainres.2010.04.071. PubMed PMID: 20450898; PubMed Central PMCID: PMC2922055.
  279. Song F, Poljak A, Valenzuela M, Mayeux R, Smythe GA, Sachdev PS. Meta-analysis of plasma amyloid-beta levels in Alzheimer's disease. Journal of Alzheimer's disease : JAD. 2011;26(2):365-75. Epub 2011/06/29. doi: 10.3233/JAD-2011-101977. PubMed PMID: 21709378; PubMed Central PMCID: PMC Journal - In Process.
  280. Sperling R, Salloway S, Brooks DJ, Tampieri D, Barakos J, Fox NC, et al. Amyloid-related imaging abnormalities in patients with Alzheimer's disease treated with bapineuzumab: a retrospective analysis. Lancet neurology. 2012;11(3):241-9. doi: 10.1016/S1474-4422(12)70015-7. PubMed PMID: 22305802; PubMed Central PMCID: PMC Journal - In Process.
  281. Sperling RA, Aisen PS, Beckett LA, Bennett DA, Craft S, Fagan AM, et al. Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement. 2011;7(3):280-92. Epub 2011/04/26. doi: 10.1016/j.jalz.2011.03.003. PubMed PMID: 21514248; PubMed Central PMCID: PMC3220946.
  282. Sproul AA, Jacob S, Pre D, Kim SH, Nestor MW, Navarro-Sobrino M, et al. Characterization and molecular profiling of PSEN1 familial Alzheimer's disease iPSC-derived neural progenitors. PloS one. 2014;9(1):e84547. doi: 10.1371/journal.pone.0084547. PubMed PMID: 24416243; PubMed Central PMCID: PMC3885572.
  283. Sproul AA, Vensand LB, Dusenberry CR, Jacob S, Vonsattel JP, Paull DJ, et al. Generation of iPSC lines from archived non-cryoprotected biobanked dura mater. Acta neuropathologica communications. 2014;2(1):4. doi: 10.1186/2051-5960-2-4. PubMed PMID: 24398250; PubMed Central PMCID: PMC3895779.
  284. Stallard E, Kinosian B, Zbrozek AS, Yashin AI, Glick HA, Stern Y. Estimation and validation of a multiattribute model of Alzheimer disease progression. Med Decis Making. 2010;30(6):625-38. Epub 2010/12/25. doi: 0272989X10363479 [pii] 10.1177/0272989X10363479. PubMed PMID: 21183754; PubMed Central PMCID: PMC Journal - In Process.
  285. Steffener J, Barulli D, Habeck C, O'Shea D, Razlighi Q, Stern Y. The role of education and verbal abilities in altering the effect of age-related gray matter differences on cognition. PloS one. 2014;9(3):e91196. doi: 10.1371/journal.pone.0091196. PubMed PMID: 24625888; PubMed Central PMCID: PMC3953380.
  286. Steffener J, Brickman AM, Habeck CG, Salthouse TA, Stern Y. Cerebral blood flow and gray matter volume covariance patterns of cognition in aging. Hum Brain Mapp. 2013;34(12):3267-79. doi: 10.1002/hbm.22142. PubMed PMID: 22806997; PubMed Central PMCID: PMC3812339.
  287. Steffener J, Habeck CG, Stern Y. Age-related changes in task related functional network connectivity. PloS one. 2012;7(9):e44421. doi: 10.1371/journal.pone.0044421. PubMed PMID: 23028536; PubMed Central PMCID: PMC3445529.
  288. Steffener J, Reuben A, Rakitin BC, Stern Y. Supporting performance in the face of age-related neural changes: testing mechanistic roles of cognitive reserve. Brain Imaging Behav. 2011;5(3):212-21. Epub 2011/05/25. doi: 10.1007/s11682-011-9125-4. PubMed PMID: 21607547; PubMed Central PMCID: PMC3169844.
  289. Steffener J, Stern Y. Exploring the neural basis of cognitive reserve in aging. Biochimica et biophysica acta. 2012;1822(3):467-73. doi: 10.1016/j.bbadis.2011.09.012. PubMed PMID: 21982946; PubMed Central PMCID: PMC3264833.
  290. Steffener J, Tabert M, Reuben A, Stern Y. Investigating hemodynamic response variability at the group level using basis functions. Neuroimage. 2010;49(3):2113-22. Epub 2009/11/17. doi: S1053-8119(09)01198-7 [pii] 10.1016/j.neuroimage.2009.11.014. PubMed PMID: 19913625; PubMed Central PMCID: PMC2818488.
  291. Stern Y. Elaborating a Hypothetical Concept: Comments on the Special Series on Cognitive Reserve. J Int Neuropsychol Soc. 2011:1-4. Epub 2011/05/11. doi: 10.1017/S1355617711000579. PubMed PMID: 21554784; PubMed Central PMCID: PMC3977966.
  292. Stern Y. Cognitive reserve in ageing and Alzheimer's disease. Lancet neurology. 2012;11(11):1006-12. doi: 10.1016/S1474-4422(12)70191-6. PubMed PMID: 23079557; PubMed Central PMCID: PMC3507991.
  293. Stern Y. Cognitive reserve: implications for assessment and intervention. Folia Phoniatr Logop. 2013;65(2):49-54. doi: 10.1159/000353443. PubMed PMID: 23941972; PubMed Central PMCID: PMC3970779.
  294. Stern Y, Blumen HM, Rich LW, Richards A, Herzberg G, Gopher D. Space Fortress game training and executive control in older adults: a pilot intervention. Neuropsychol Dev Cogn B Aging Neuropsychol Cogn. 2011;18(6):653-77. Epub 2011/10/13. doi: 10.1080/13825585.2011.613450. PubMed PMID: 21988726; PubMed Central PMCID: PMC3591462.
  295. Stern Y, Rakitin BC, Habeck C, Gazes Y, Steffener J, Kumar A, et al. Task difficulty modulates young-old differences in network expression. Brain Res. 2012;1435:130-45. doi: 10.1016/j.brainres.2011.11.061. PubMed PMID: 22197699; PubMed Central PMCID: PMC3406734.
  296. Sun X, Liu J, Crary JF, Malagelada C, Sulzer D, Greene LA, et al. ATF4 protects against neuronal death in cellular Parkinson's disease models by maintaining levels of parkin. J Neurosci. 2013;33(6):2398-407. doi: 10.1523/JNEUROSCI.2292-12.2013. PubMed PMID: 23392669; PubMed Central PMCID: PMC3711618.
  297. Swaminathan S, Huentelman MJ, Corneveaux JJ, Myers AJ, Faber KM, Foroud T, et al. Analysis of copy number variation in Alzheimer's disease in a cohort of clinically characterized and neuropathologically verified individuals. PloS one. 2012;7(12):e50640. doi: 10.1371/journal.pone.0050640. PubMed PMID: 23227193; PubMed Central PMCID: PMC3515604.
  298. Swaminathan S, Shen L, Kim S, Inlow M, West JD, Faber KM, et al. Analysis of copy number variation in Alzheimer's disease: the NIALOAD/ NCRAD Family Study. Current Alzheimer research. 2012;9(7):801-14. PubMed PMID: 22486522; PubMed Central PMCID: PMC3500615.
  299. Sweet RA, Bennett DA, Graff-Radford NR, Mayeux R. Assessment and familial aggregation of psychosis in Alzheimer's disease from the National Institute on Aging Late Onset Alzheimer's Disease Family Study. Brain : a journal of neurology. 2010;133(Pt 4):1155-62. Epub 2010/02/12. doi: awq001 [pii] 10.1093/brain/awq001. PubMed PMID: 20147454; PubMed Central PMCID: PMC2912688.
  300. Thenganatt MA, Alcalay RN, Vonsattel JP, Greene PE. Somatic mitochondrial DNA mutations and parkinsonism. Annals of neurology. 2012;72(5):823; author reply -4. doi: 10.1002/ana.23740. PubMed PMID: 23280801; PubMed Central PMCID: PMC Journal - In Process.
  301. Tucker AM, Rakitin BC, Basner RC, Gazes Y, Steffener J, Stern Y. fMRI activation during failures to respond key to understanding performance changes with sleep deprivation. Behavioural brain research. 2011;218(1):73-9. Epub 2010/11/16. doi: 10.1016/j.bbr.2010.11.012. PubMed PMID: 21074577; PubMed Central PMCID: PMC3022081.
  302. Tucker AM, Stern Y. Cognitive reserve in aging. Current Alzheimer research. 2011;8(4):354-60. Epub 2011/01/13. PubMed PMID: 21222591; PubMed Central PMCID: PMC3135666.
  303. Tucker AM, Stern Y, Basner RC, Rakitin BC. The prefrontal model revisited: double dissociations between young sleep deprived and elderly subjects on cognitive components of performance. Sleep. 2011;34(8):1039-50. Epub 2011/08/02. doi: 10.5665/SLEEP.1158. PubMed PMID: 21804666; PubMed Central PMCID: PMC3138159.
  304. van Blitterswijk M, Baker MC, DeJesus-Hernandez M, Ghidoni R, Benussi L, Finger E, et al. C9ORF72 repeat expansions in cases with previously identified pathogenic mutations. Neurology. 2013;81(15):1332-41. doi: 10.1212/WNL.0b013e3182a8250c. PubMed PMID: 24027057; PubMed Central PMCID: PMC3806926.
  305. Van Deerlin VM, Sleiman PM, Martinez-Lage M, Chen-Plotkin A, Wang LS, Graff-Radford NR, et al. Common variants at 7p21 are associated with frontotemporal lobar degeneration with TDP-43 inclusions. Nat Genet. 2010;42(3):234-9. Epub 2010/02/16. doi: ng.536 [pii] 10.1038/ng.536. PubMed PMID: 20154673; PubMed Central PMCID: PMC2828525.
  306. Vardarajan B, Vergote D, Tissir F, Logue M, Yang J, Daude N, et al. Role of p73 in Alzheimer disease: lack of association in mouse models or in human cohorts. Mol Neurodegener. 2013;8(1):10. doi: 10.1186/1750-1326-8-10. PubMed PMID: 23414597; PubMed Central PMCID: PMC3614544.
  307. Vardarajan BN, Faber KM, Bird TD, Bennett DA, Rosenberg R, Boeve BF, et al. Age-Specific Incidence Rates for Dementia and Alzheimer Disease in NIA-LOAD/NCRAD and EFIGA Families: National Institute on Aging Genetics Initiative for Late-Onset Alzheimer Disease/National Cell Repository for Alzheimer Disease (NIA-LOAD/NCRAD) and Estudio Familiar de Influencia Genetica en Alzheimer (EFIGA). JAMA neurology. 2014;71(3):315-23. doi: 10.1001/jamaneurol.2013.5570. PubMed PMID: 24425039; PubMed Central PMCID: PMC Journal - In Process.
  308. Vieira SI, Rebelo S, Esselmann H, Wiltfang J, Lah J, Lane R, et al. Retrieval of the Alzheimer's amyloid precursor protein from the endosome to the TGN is S655 phosphorylation state-dependent and retromer-mediated. Mol Neurodegener. 2010;5:40. Epub 2010/10/13. doi: 1750-1326-5-40 [pii] 10.1186/1750-1326-5-40. PubMed PMID: 20937087; PubMed Central PMCID: PMC2994555.
  309. Vonsattel JP, Keller C, Cortes Ramirez EP. Huntington's disease - neuropathology. Handbook of clinical neurology / edited by PJ Vinken and GW Bruyn. 2011;100:83-100. Epub 2011/04/19. doi: 10.1016/B978-0-444-52014-2.00004-5. PubMed PMID: 21496571; PubMed Central PMCID: PMC Journal - In Process.
  310. Wang JW, Beck ES, McCabe BD. A modular toolset for recombination transgenesis and neurogenetic analysis of Drosophila. PloS one. 2012;7(7):e42102. doi: 10.1371/journal.pone.0042102. PubMed PMID: 22848718; PubMed Central PMCID: PMC3405054.
  311. Wang JW, Brent JR, Tomlinson A, Shneider NA, McCabe BD. The ALS-associated proteins FUS and TDP-43 function together to affect Drosophila locomotion and life span. The Journal of clinical investigation. 2011;121(10):4118-26. Epub 2011/09/02. doi: 10.1172/JCI57883. PubMed PMID: 21881207; PubMed Central PMCID: PMC3195475.
  312. Wiegman AF, Meier IB, Provenzano FA, Schupf N, Manly JJ, Stern Y, et al. Regional white matter hyperintensity volume and cognition predict death in a multiethnic community cohort of older adults. Journal of the American Geriatrics Society. 2013;61(12):2246-8. doi: 10.1111/jgs.12568. PubMed PMID: 24329833; PubMed Central PMCID: PMC3874729.
  313. Wijsman EM, Pankratz ND, Choi Y, Rothstein JH, Faber KM, Cheng R, et al. Genome-wide association of familial late-onset Alzheimer's disease replicates BIN1 and CLU and nominates CUGBP2 in interaction with APOE. PLoS Genet. 2011;7(2):e1001308. Epub 2011/03/08. doi: 10.1371/journal.pgen.1001308. PubMed PMID: 21379329; PubMed Central PMCID: PMC3040659.
  314. Willey JZ, Scarmeas N, Provenzano FA, Luchsinger JA, Mayeux R, Brickman AM. White matter hyperintensity volume and impaired mobility among older adults. J Neurol. 2013;260(3):884-90. doi: 10.1007/s00415-012-6731-z. PubMed PMID: 23128969; PubMed Central PMCID: PMC3594567.
  315. Wilson RS, Barral S, Lee JH, Leurgans SE, Foroud TM, Sweet RA, et al. Heritability of different forms of memory in the Late Onset Alzheimer's Disease Family Study. Journal of Alzheimer's disease : JAD. 2011;23(2):249-55. Epub 2010/10/12. doi: 10.3233/JAD-2010-101515. PubMed PMID: 20930268; PubMed Central PMCID: PMC3130303.
  316. Wilson RS, Leurgans SE, Foroud TM, Sweet RA, Graff-Radford N, Mayeux R, et al. Telephone assessment of cognitive function in the late-onset Alzheimer's disease family study. Archives of neurology. 2010;67(7):855-61. Epub 2010/07/14. doi: 67/7/855 [pii] 10.1001/archneurol.2010.129. PubMed PMID: 20625093; PubMed Central PMCID: PMC2971664.
  317. Wu JW, Herman M, Liu L, Simoes S, Acker CM, Figueroa H, et al. Small misfolded Tau species are internalized via bulk endocytosis and anterogradely and retrogradely transported in neurons. The Journal of biological chemistry. 2013;288(3):1856-70. doi: 10.1074/jbc.M112.394528. PubMed PMID: 23188818; PubMed Central PMCID: PMC3548495.
  318. Wylie MA, Shnall A, Onyike CU, Huey ED. Management of frontotemporal dementia in mental health and multidisciplinary settings. International review of psychiatry. 2013;25(2):230-6. doi: 10.3109/09540261.2013.776949. PubMed PMID: 23611352; PubMed Central PMCID: PMC3929950.
  319. Xi Z, Zinman L, Grinberg Y, Moreno D, Sato C, Bilbao JM, et al. Investigation of c9orf72 in 4 neurodegenerative disorders. Archives of neurology. 2012;69(12):1583-90. doi: 10.1001/archneurol.2012.2016. PubMed PMID: 22964832; PubMed Central PMCID: PMC Journal - In Process.
  320. Yoshizawa H, Gazes Y, Stern Y, Miyata Y, Uchiyama S. Characterizing the normative profile of 18F-FDG PET brain imaging: sex difference, aging effect, and cognitive reserve. Psychiatry Res. 2014;221(1):78-85. doi: 10.1016/j.pscychresns.2013.10.009. PubMed PMID: 24262800; PubMed Central PMCID: PMC Journal - In Process.
  321. Yoshizawa H, Vonsattel JP, Honig LS. Early neuropsychological discriminants for Lewy body disease: an autopsy series. Journal of neurology, neurosurgery, and psychiatry. 2013. doi: 10.1136/jnnp-2012-304381. PubMed PMID: 23308020; PubMed Central PMCID: PMC Journal - In Process.
  322. Yoshizawa H, Vonsattel JP, Honig LS. Presenting neuropsychological testing profile of autopsy-confirmed frontotemporal lobar degeneration. Dement Geriatr Cogn Disord. 2013;36(5-6):279-89. doi: 10.1159/000353860. PubMed PMID: 23949428; PubMed Central PMCID: PMC Journal - In Process.
  323. Zahodne LB, Devanand DP, Stern Y. Coupled cognitive and functional change in Alzheimer's disease and the influence of depressive symptoms. Journal of Alzheimer's disease : JAD. 2013;34(4):851-60. doi: 10.3233/JAD-121921. PubMed PMID: 23302654; PubMed Central PMCID: PMC3768289.
  324. Zahodne LB, Manly JJ, Brickman AM, Siedlecki KL, Decarli C, Stern Y. Quantifying cognitive reserve in older adults by decomposing episodic memory variance: replication and extension. J Int Neuropsychol Soc. 2013;19(8):854-62. doi: 10.1017/S1355617713000738. PubMed PMID: 23866160; PubMed Central PMCID: PMC3777696.
  325. Zahodne LB, Manly JJ, MacKay-Brandt A, Stern Y. Cognitive declines precede and predict functional declines in aging and Alzheimer's disease. PloS one. 2013;8(9):e73645. doi: 10.1371/journal.pone.0073645. PubMed PMID: 24023894; PubMed Central PMCID: PMC3759461.
  326. Zahodne LB, Ornstein K, Cosentino S, Devanand DP, Stern Y. Longitudinal Relationships Between Alzheimer Disease Progression and Psychosis, Depressed Mood, and Agitation/Aggression. Am J Geriatr Psychiatry. 2013. doi: 10.1016/j.jagp.2013.03.014. PubMed PMID: 23871118; PubMed Central PMCID: PMC3858495.
  327. Zahodne LB, Schofield PW, Farrell MT, Stern Y, Manly JJ. Bilingualism does not alter cognitive decline or dementia risk among Spanish-speaking immigrants. Neuropsychology. 2014;28(2):238-46. doi: 10.1037/neu0000014. PubMed PMID: 24188113; PubMed Central PMCID: PMC3947427.
  328. Zhao Q, Lee JH, Pang D, Temkin A, Park N, Janicki SC, et al. Estrogen receptor-Beta variants are associated with increased risk of Alzheimer's disease in women with down syndrome. Dement Geriatr Cogn Disord. 2011;32(4):241-9. Epub 2011/12/14. doi: 10.1159/000334522. PubMed PMID: 22156442; PubMed Central PMCID: PMC3250648.
  329. Zhu CW, Livote EE, Kahle-Wrobleski K, Scarmeas N, Albert M, Brandt J, et al. Utilization of antihypertensives, antidepressants, antipsychotics, and hormones in Alzheimer disease. Alzheimer disease and associated disorders. 2010. Epub 2010/10/27. doi: 10.1097/WAD.0b013e3181fcba68. PubMed PMID: 20975515; PubMed Central PMCID: PMC3075380.
  330. Zhu CW, Livote EE, Kahle-Wrobleski K, Scarmeas N, Albert M, Brandt J, et al. Longitudinal Medication Usage in Alzheimer Disease Patients. Alzheimer disease and associated disorders. 2010. Epub 2010/07/14. doi: 10.1097/WAD.0b013e3181e6a17a. PubMed PMID: 20625271; PubMed Central PMCID: PMC3087865.
  331. Zhu CW, Livote EE, Scarmeas N, Albert M, Brandt J, Blacker D, et al. Long-term associations between cholinesterase inhibitors and memantine use and health outcomes among patients with Alzheimer's disease. Alzheimers Dement. 2013. doi: 10.1016/j.jalz.2012.09.015. PubMed PMID: 23332671; PubMed Central PMCID: PMC3633652.
  332. Zou F, Chai HS, Younkin CS, Allen M, Crook J, Pankratz VS, et al. Brain expression genome-wide association study (eGWAS) identifies human disease-associated variants. PLoS Genet. 2012;8(6):e1002707. doi: 10.1371/journal.pgen.1002707. PubMed PMID: 22685416; PubMed Central PMCID: PMC3369937.
  333. Zou WQ, Puoti G, Xiao X, Yuan J, Qing L, Cali I, et al. Variably protease-sensitive prionopathy: a new sporadic disease of the prion protein. Annals of neurology. 2010;68(2):162-72. Epub 2010/08/10. doi: 10.1002/ana.22094. PubMed PMID: 20695009; PubMed Central PMCID: PMC3032610.